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ABSTRACT
Platinum is the metal present in various classes of inorganic medicinal agents directed at
important diseases such as cancer or viral infections. Several new Pt(II) complexes of polyamine
ligands bearing a dansyl moiety linked by a sulfonamide group were prepared; in some cases the
sulfonamide nitrogen formed a bond to Pt. The sulfonamido group donates strongly to Pt and
places the dansyl group close to a vacant coordination position, allowing it to stack with bound
guanine base (G) when G binds. The emission of the fluorophore decreases with decreasing
distance to Pt.
Metal nuclide radiopharmaceuticals contain a metal core and an inner ligating unit,
usually having chelate rings. The development of the advantageous fac-[99mTc(CO)3(H2O)3]+
precursor has opened new directions for radiolabeling.

The non-radioactive fac-

[Re(CO)3(H2O)3]+ analogue is useful in understanding the chemistry of agents derived from the
[99mTc(CO)3(H2O)3]+ species. To achieve a net neutral coordination unit in radiopharmaceuticals
with a fac-M(CO)3+ core (M = Tc, Re), facially coordinated monoanionic tridentate ligands (L¯)
are needed.

Several fac-[Re(CO)3L] complexes containing the sulfonamido group as one

terminal ligating group were synthesized and characterized by X-ray crystallography and NMR
spectroscopy.

For most sulfonamido complexes studied here, the two chelate rings have

different pucker chirality, as is commonly found for a broad range of metal complexes. The
complexes are stable at neutral and basic pH values and thus have potential for providing a
neutral label in radiopharmaceuticals. The NMR signal averaging indicates that the rotations
about the N−S and S−C bonds of the sulfonamido group are rapid on the NMR time scale.
Understanding the chemical features of the prototypical complexes by using the fac[Re(CO)3L]-analogue approach and the minimal ligand was the goal of this part of this
investigation.

fac-[Re(CO)3L]+ complexes containing prototypical NNN or NSN tridentate
vi

ligands, such as diethylenetriamine (dien) and simple dien derivatives, were investigated by Xray crystallographic and NMR methods. fac-[Re(CO)3L]+ complexes with two terminal exo-NH
groups exhibit unusually upfield exo-NH NMR signals, which shift downfield on addition of Cl¯
indicating 1:1 ion pairs forms involving one Cl¯ to two exo-NH's H-bonds.

vii

CHAPTER 1. INTRODUCTION
Inorganic compounds have found extensive usage as chemotherapeutic agents.1 Examples
include the anticancer agent cisplatin (cis-[Pt(NH3)2Cl2]), the gold-containing antiarthritic drug
Auranofin, gadolinium compounds used as magnetic resonance imaging-enhancing agents and
99m-technetium compounds used as radiopharmaceuticals in disease diagnosis.2
1.1 cis-[Pt(NH3)2Cl2]
Platinum anticancer compounds are probably the most studied inorganic drugs in history
and that because cisplatin is the only anticancer agent known to cure a malignancy.2-4 Cisplatin is
used to treat a variety of cancers, such as head, neck, lung and bladder cancer.3,5 Upon entrance
to the cell, the cisplatin chloro ligands are displaced by water. Water is a good leaving group, and
therefore an aqua cation formed by cisplatin is thought to be the reactive form in vivo. Within the
cell, cisplatin interacts with a number of biomolecules such as peptides (glutathione), proteins
and nucleic acids. Eventually though, it is well established that the final target of cisplatin is the
N7 of guanine bases of DNA.3,5 Binding causes the DNA strand to bend by an angle of ~40-50°.
Interaction of the platinated DNA with cellular proteins, particularly high mobility group domain
proteins, increase the bending of the helix and possibly prevent repair by the DNA-repair
proteins, thus preventing replication and eventually causing cell death.3
Platinum is present in various classes of metal-containing medicinal agents directed at
important diseases such as cancer or viral infections.3,4,6,7 The high affinity toward the N7 of
purines, particularly guanine, in nucleic acids4,8 is a key feature of the Pt(II) center that may be
an important property endowing Pt(II) agents with these valuable types of biological activity.
Platinum drugs are clearly among the most efficious drugs active against a broad range of
cancers.3 Pt drugs would find wider use except for the well-known toxicity generally attributed
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to the reaction of the Pt drugs with the sulfur atoms in biological thiols and thioethers, such as
cysteine and methionine residues.9 Thus, it is an important goal to identify features that reduce S
binding while maintaining N7 binding.
1.2 fac-[M(CO)3(H2O)3]+ (M = Tc or Re)
Radiopharmaceuticals compounds, containing a radionuclide, are used widely for the
diagnosis or therapy of various diseases. Metalloradiopharmaceuticals contain a metal core and
an inner ligating unit (usually having chelate rings). We refer to the core and inner ligating unit
as a label. The important properties of the label, which influence biological behavior, are charge
and overall shape. Technetium-99m (99mTc) is the radionuclide that is most widely used in
diagnostic nuclear medicine.10-13 {99mTc(V)O}3+ has been the metal core used most
predominantly. [99mTcO(MAG3)]2- (MAG3 = penta-anionic form of mercaptoacetyltriglycine in
which the mercapto, amide and carboxyl groups are deprotonated) is the most widely used renal
radiopharmaceuticals based on the {99mTc(V)O}3+ core.
Radiopharmaceuticals based on the fac-[99mTc(CO)3]+ core are gaining extensive use
because the fac-[99mTc(CO)3(H2O)3]+ precursor can be conveniently generated.14-17 Schibli et al.
showed that agents with the fac-99mTc(I)(CO)3+ core bearing a tridentate coordinated ligand are
more robust and have better pharmacokinetic profiles than agents bearing bidentate ligands.18 A
recent straightforward preparation of aqueous solutions of the non-radioactive fac[Re(CO)3(H2O)3]+ precursor19 has made the synthesis of fac-[Re(CO)3L] analogues convenient
and allows simulation of the aqueous 99mTc synthetic chemistry.19,20
Commonly employed chelating ligands (e.g., diethylenetriamine (dien),21 cysteine- and
homocysteine-based ligands19,20) contain N, O, or S donor atoms in groups such as carboxyls,22
amines,23-29 nitrogen heterocycles,24-26 and thioethers.19,20,26,27 Extensively characterized fac-
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[Re(CO)3L] complexes of a series of symmetric and non-symmetric NNN or NSN ligands
containing combinations of amine, pyrazolyl, and thioether donors are known.25-27 During the
development of radiopharmaceutical renal agents, polyamino-polycarboxylic acid ligands have
been investigated.23,30 At high pH amine group coordination is preferred, allowing for dangling
carboxyl groups, which are important in high renal clearance.23,30 Other studies involving
nitrogen, sulfur and oxygen donors have proposed that nitrogen donor ligands are better than
sulfur donor ligands for the fac-[Re(CO)3L] complex formation.31,32 The

99m

Tc-tagged

lanthionine agents were the first small fac-[99mTc(CO)3L] agents reported to have been evaluated
in humans;33 thus, additional studies directed at gaining a more comprehensive assessment of
conformation are warranted.
An important approach in the development of small (~5 kDa) metal nuclide
radiopharmaceuticals is the bioconjugation of a net neutral label to hormones, small peptides,
etc.34 For fac-99mTc(I)(CO)3+ agents, the ligand(s) occupying the three remaining coordination
sites must have one negative group close to the metal for net neutrality. A coordinated
carboxylate group provides such a unit, but it does not provide a point for ligand elaboration or
for bioconjugation. Consequently, there is a need to evaluate other groups within tridentate
monoanionic ligands.
1.3 Sulfonamide Ligands
Even though the sulfonamide group has been used extensively as a linking group in
organic chemistry, it is in general a neglected ligand donor group for metal complexes. It has
been shown that sulfonamide ligands bind well to several metals

35-40

but compared to other

nitrogen-bearing ligands, reports of metal complexes of sulfonamide ligands are few. Even
though, there are some reports of Pt(II) sulfonamido complexes41-43 none of them investigated

3

reactions with biomolecules. In the first part of this study, we prepared Pt(II) complexes of NNN
tridentate ligands which have a sulfonamide linkage to a fluorescent group.39 These compounds
presented us with the opportunity to investigate the effect of the fluorophore on the fluorescence
and the properties of complexes with small biomolecules and to indentify the effect of the
sulfonamido group on the selectivity of S vs. N7 binding.39 To our knowledge, the Tc(I) and
Re(I) complexes of sulfonamido ligands have never been studied. As a prelude to
radiopharmaceutical studies, we analyzed a series of new neutral Re(CO)3L complexes
containing sulfonamide ligands which bind in a tridentate fashion involving one nitrogen of a
monoanionic deprotonated sulfonamido group.44
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CHAPTER 2. THE NEGLECTED Pt−N(SULFONAMIDO) BOND IN PLATINUM
CHEMISTRY. NEW FLUOROPHORE-CONTAINING PLATINUM COMPLEXES
USEFUL FOR ASSESSING PLATINUM INTERACTIONS WITH BIOMOLECULES*
2.1 Introduction
Platinum is the metal present in various classes of inorganic medicinal agents directed at
important diseases such as cancer or viral infections.1-4 An important feature of the Pt(II) center
that may be a key property endowing Pt(II) agents with these important types of activity is the
high affinity toward the N7 of purines, particularly guanine, in nucleic acids.2,5 Platinum drugs
are perhaps the best single type of anticancer drug active against a broad range of cancers.1 Pt
drugs would find wider use except for the well-known toxicity resulting from the reaction of the
drugs with biological thiols and thioethers.6 Thus, it is highly desirable to identify features that
reduce S binding while maintaining N7 binding.
Reactions of the monofunctional complex, [Pt(dien)Cl]Cl (dien = diethylenetriamine),
with nucleotides have been studied extensively as an aid in assessing the nature of DNA binding
of difunctional Pt(II) anticancer drugs (e.g., cisplatin).2,7

A study of the reaction rates of

[Pt(dien)Cl]Cl with 5′-GMP (5′-GMP = 5′-guanosine monophosphate) and peptides [glutathione
(GSH) and S-methylglutathione (GSMe) as models for cysteine and L-methionine (met) binding
sites, respectively] showed that the Pt−sulfur bond is formed much more rapidly than the Pt−N7
bond.6 Several other studies, including competitive reactions of [Pt(dien)Cl]Cl with met and 5′GMP (revealing that the kinetic product was Pt(dien)(met) and that the thermodynamic product
was Pt(dien)(5′-GMP)), all indicate the same trend.8-10
*

Reproduced with permission from American Chemical Society: Christoforou, A. M., Marzilli,
P. A., Marzilli, L. G., “The Neglected Pt−N(sulfonamido) Bond in Pt Chemistry. New
Fluorophore-Containing Pt(II) Complexes Useful for Assessing Pt(II) Interactions with
Biomolecules,” Inorganic Chemistry, 2006, 45, 6771-6781. Copyright 2006 American Chemical
Society.
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Many Pt(II) complexes with ligands having the dien backbone have been synthesized and
studied,

e.g.,

N,N′,N′′-trimethyldiethylenetriamine

(N-Me3dien),

N,N,N′,N′′,N′′-

pentamethyldiethylenetriamine (N-Me5dien), and N,N,N'',N''-tetramethyldiethylenetriamine (NMe4dien).11-13 Preferential binding of [Pt(N-Me4dien)Cl]Cl to the sulfur of glutathione and the
absence of binding to an imidazole nitrogen of histidine was attributed to steric effects.13

Figure 2.1. Fluorescent ligands used in this study.

In this study, we explore the chemistry of complexes with tridentate ligands bearing a
sulfonamide and an aromatic fluorescent group. The ligands (Figure 2.1) used in this study are
N-(2-((2-aminoethyl)amino)ethyl)-5-(dimethylamino)naphthalene-1-sulfonamide (DNSH-dienH,
where

DNSH

=

5-(dimethylamino)naphthalene-1-sulfonamide)

and

N-(2-(bis(2-

aminoethyl)amino)ethyl)-5-(dimethylamino)naphthalene-1-sulfonamide (DNSH-tren, where tren
= tris(2-aminoethyl)amine). (The H indicates protons displaceable upon Pt binding, i.e., the

8

sulfonamide NH for the dienH moiety and the H8 for the DNSH moiety). The DNSH-dienH
ligand afforded the Pt(DNSH-dienH)Cl2, Pt(DNSH-dien)X (X = Cl, Br), and Pt(DNS-dien)
complexes, whereas DNSH-tren gave [Pt(DNSH-tren)Cl]Cl (Figure 2.2). These compounds
presented us with the opportunity to investigate the effect of the fluorophore and the properties
of complexes with small biomolecules such as 9-substituted derivatives of guanine (G) or of
hypoxanthine (3′-inosine monophosphate, 3′-IMP).

Figure 2.2. Pt(II) complexes synthesized in this study: Pt(DNSH-dienH)Cl2 (1), Pt(DNSHdien)Cl (2), Pt(DNSH-dien)Br (3), Pt(DNS-dien) (4), and [Pt(DNSH-tren)Cl]Cl (5).
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2.2 Experimental Section
2.2.1 Starting Materials
Tren from Strem, N′-Me-dien (N′-Me-dien = N-methyl-2,2′-diaminodiethylamine) from
TCI America, Pt(en)Cl2, N-Et-en = N-ethylethylenediamine and dien from Aldrich, and the
following materials from Sigma: dansyl chloride (DNSH-Cl), 9-ethylguanine (9-EtG), and the
sodium salts of 3′-guanosine monophosphate (3′-GMP), 5′-GMP, 5′-guanosine diphosphate (5′GDP), 5′-guanosine triphosphate (5′-GTP), 3′-IMP, and met were all used as received. The
DNSH-dienH and DNSH-tren ligands were prepared by known methods,14,15 and their 1H NMR
chemical shifts matched the reported values.

Cis-Pt(Me2SO)2Cl2,16 cis-Pt(Me2SO)2Br2,17

[Pt(dien)Cl]Cl,18 Pt(N-Et-en)Cl2,19 and [Pt(N′-Me-dien)Cl]Cl20 were prepared as described in the
literature.
2.2.2 Physical Measurements
2.2.2.1 NMR Spectroscopy. 1H, 13C, and

195

Pt NMR spectra were recorded on either a

400 MHz or a 500 MHz Bruker NMR spectrometer using DMSO-d6, except for 1H NMR studies
of adduct formation performed in D2O/DMSO-d6 solutions. Typical concentrations were 10 mM
for 1H and

13

C NMR and 50 mM for

195

Pt NMR measurements. Peak positions are relative to

TMS (for 1H and 13C in DMSO-d6) or the residual water signal (for 1H in D2O/DMSO-d6). All
NMR data were processed using XWINNMR and Mestre-C software. 1H-1H COSY and ROESY
as well as 1H-13C HSQC and HMBC NMR spectra were recorded in order to assign the signals of
the products. 512 × 2048 matrices were collected for the 1H-13C HSQC and HMBC experiments.
Typically, 256 scans were collected per block, and an exponential apodization function with a
line broadening of 0.2 Hz was used. The typical JH-C in HMBC experiments was 8 Hz unless
otherwise stated. The COSY experiments were performed at 25 °C with 16 scans per t1
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increment. The evolution dimension was zero-filled to 2K prior to Fourier transformation. 2D
ROESY experiments were performed at 25 °C by using mixing times of 300 ms (64 scans per t1
increment). For 195Pt NMR spectra a pulse width of 20 μs, corresponding to a 30° tip angle, was
used with a relaxation delay of 0.4 s. Usually, several acquisitions were recorded using a spectral
window of 75,000 Hz, with 16K data points. Typically 10,000 scans were averaged for each
acquisition, and the resulting FID was multiplied by an exponential function (LB = 50 Hz) prior
to Fourier transformation.

All

195

Pt NMR chemical shifts were determined in DMSO-d6

solutions by using cis-Pt(Me2SO)2Cl2 (-3450 ppm) as an external reference, compared to a
Na2PtCl6 standard.21 Because the shift effect of the deprotonated sulfonamide of Pt(DNSHdien)Cl was not as large as expected from the literature on the shift effect of deprotonated
peptides,22 we examined a particularly wide spectral region from -1300 to -9400 ppm to ensure
that the signal reported below was from this complex.
2.2.2.2 Fluorescence Spectroscopy. Spectra of Pt(II) complexes and 5′-GMP adducts (5
μM solution in H2O/DMSO-d6, v/v 5/1, pH = 5.5) were recorded in a 10 mm quartz fluorescence
cuvette, at room temperature, in triplicate by using a Spex Fluorolog-3 spectrofluorimeter
equipped with a 450 W xenon lamp and a photomultiplier tube detector; all the spectra were
blank subtracted. Emission spectra were recorded at the excitation wavelength, 360 nm.
2.2.3 Synthesis of Pt(II) Complexes
2.2.3.1 Synthesis of Pt(DNSH-dienH)Cl2 (1). A suspension of cis-Pt(Me2SO)2Cl2 (150
mg, 0.355 mmol) in methanol (20 mL) was treated with DNSH-dienH (119 mg, 0.355 mmol),
and the reaction mixture was stirred at room temperature for 24 h. Acetonitrile (60 mL) was
added slowly to the solution and the yellow solid that precipitated was collected on a filter,
washed with water and diethyl ether, and dried under vacuum; yield, 87 mg (41%). 1H NMR
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spectrum (DMSO-d6) (ppm): 8.48 (d, 1H), 8.27 (d, 1H), 8.22 (t, 1H, NH), 8.13 (d, 1H), 7.61 (m,
2H), 7.25 (d, 1H), 6.98 (s, 1H , NH), 6.15 (s, 2H, NH), 3.42 (s, 2H, CH2), 3.38 (m, 2H, CH2),
3.15 (m, 4H, CH2), 2.83 (s, 6H, CH3). Anal. Calcd for C16H24Cl2N4O2PtS•1.5H2O•CH3OH: C,
30.87; H, 4.72; N, 8.47. Found: C, 31.09; H, 4.57; N, 8.02.
2.2.3.2 Synthesis of Pt(DNSH-dien)Cl (2). The Pt(DNSH-dien)Cl complex was
synthesized as above for complex 1, but with triethylamine (40 μL, 0.293 mmol) added to the
methanol suspension of cis-Pt(Me2SO)2Cl2 immediately after addition of DNSH-dienH. The
yellow solid that precipitated from the reaction mixture after 24 h of stirring was collected on a
filter, washed with diethyl ether, and dried under vacuum; yield, 90 mg (45%). 1H NMR
spectrum (DMSO-d6) (ppm): 8.60 (d, 1H), 8.39 (d, 1H), 8.27 (d, 1H), 7.47 (m, 2H), 7.15 (d, 1H),
6.61 (s, 1H, NH), 5.29 (s, 1 H, NH), 5.11 (s, 1H, NH), 3.18 (m, 2H, CH2), 2.94 (m, 4H, CH2),
2.82 (s, 6H, CH3), 2.65 (m, 2H, CH2). Anal. Calcd for C16H23ClN4O2PtS•0.5CH3OH: C, 34.08;
H, 4.31; N, 9.59. Found: C, 34.47; H, 4.52; N, 9.81.
2.2.3.3 Synthesis of Pt(DNSH-dien)Br (3). A suspension of cis-Pt(Me2SO)2Br2 (178
mg, 0.355 mmol) in methanol (20 mL) was treated with DNSH-dienH (119 mg, 0.355 mmol)
and triethylamine (40 μL, 0.293 mmol), and the reaction mixture was stirred at room temperature
for 18 h. The pale yellow solid that precipitated was collected on a filter, washed with diethyl
ether, and dried under vacuum; yield, 91 mg (42%). 1H NMR spectrum (DMSO-d6) (ppm): 8.62
(d, 1H), 8.38 (d, 1H), 8.27 (d, 1H), 7,49 (t, 1H), 7.44 (t, 1H), 7.17 (d, 1H), 6.64 (s, 1H, NH), 5.32
(s, 1H, NH), 5.14 (s, 1H , NH), 3.29 (d, 2H, CH2), 3.05 (m, 4H, CH2), 2.81 (s, 6H, CH3), 2.65
(m, 2H, CH2). Anal. Calcd for C16H23BrN4O2PtS•H2O: C, 30.58; H, 4.01; N, 8.92. Found: C,
30.64; H, 3.81; N, 8.79.
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2.2.3.4 Synthesis of Pt(DNS-dien) (4). Pt(DNS-dien) was synthesized as described for
complex 2, but with a 10-fold excess of triethylamine added (500 μL, 3.66 mmol). Yield of
yellow solid, 136 mg (72%). 1H NMR spectrum (DMSO-d6) (ppm): 8.27 (d, 1H), 7.98 (d, 1H),
7.36 (t, 1H), 7.22 (d, 1H), 6.81 (d, 1H), 5.72 (s, 1H, NH), 5.53 (s, 1H, NH), 5.42 (s, 1H, NH),
3.64 (m, 2H, CH2), 3.16 (m, 2H CH2), 2.84 (m, 2H, CH2), 2.71 (s, 6H, CH3), 2.64 (m, 2H, CH2).
Anal. Calcd for C16H22N4O2PtS•0.5CH3OH: C, 36.41; H, 4.43; N, 10.25. Found: C, 36.41; H,
4.07; N 10.11.
2.2.3.5 Synthesis of [Pt(DNSH-tren)Cl]Cl (5). A suspension of cis-Pt(Me2SO)2Cl2 (200
mg, 0.474 mmol) in methanol (20 mL) was treated with DNSH-tren (180 mg, 0.474 mmol), and
the reaction mixture was heated at reflux for 1 h. The pale yellow solid that precipitated after
reducing the volume to 5 mL was collected on a filter, washed with water and diethyl ether, and
dried in vacuo; yield, 105 mg (35%). 1H NMR spectrum (DMSO-d6) (ppm): 8.48 (d, 1H), 8.24 (t,
1H, NH), 8.23 (d, 1H), 8.13 (d, 1H), 7.65 (m, 1H), 7.26 (d, 1H), 5.66 (s, 1H, NH), 5.37 (s, 2H,
NH), 3.46 (t, 2H, CH2), 3.07 (m, 2H, CH2), 2.76 (m, 4H, CH2), 2.82 (s, 6H, CH3). Anal. Calcd
for C18H29Cl2N5O2PtS•2H2O: C, 31.72; H, 4.88; N, 10.28. Found: C, 31.74; H, 4.74; N, 9.99.
2.2.4 Formation of Biological Adducts
Solutions to study formation of adducts (5 mM in Pt) utilized D2O/DMSO-d6 (500
μL/100 μL) solutions. DMSO-d6 was used to improve solubility; however solutions of both
Pt(DNSH-dien)Cl and [Pt(DNSH-tren)Cl]Cl with a higher percentage of water were readily
prepared (e.g. 5 mM in 95% H2O and 0.1 mM in 99.9% H2O).
2.2.4.1 G/3′-IMP Reactions. Solutions of adducts (5 mM) were prepared by treatment of
Pt(DNSH-dien)Cl or [Pt(DNSH-tren)Cl]Cl in D2O/DMSO-d6 (500 μL/100 μL) with a
stoichiometric amount of a guanine (G) or hypoxanthine derivative (3′-IMP) at pH ~ 5 (pH was

13

uncorrected). Reactions were monitored by 1H NMR spectroscopy until the disappearance of free
G/3′-IMP was indicated or until a constant intensity ratio between free and complexed G/3′-IMP
was attained. When necessary, DNO3 and NaOD solutions (0.01 M in D2O) were used for
adjusting the pH of each sample directly in the NMR tubes. 1D and 2D NMR studies were
performed at 25 °C. Methanol-d4 was added to the samples for low-temperature experiments.
2.2.4.2 Methionine Reactions. We chose conditions, such as pH, and ratios to mimic
those reported previously for the parent compound, [Pt(dien)Cl]Cl.8 Challenge Reactions.
Solutions of Pt(DNSH-dien)Cl or [Pt(DNSH-tren)Cl]Cl in D2O/DMSO-d6 (500 μL/100 μL) were
treated with a stoichiometric amount of methionine at pH ~6.4. Reactions were monitored by 1H
NMR spectroscopy until the disappearance of free met was indicated or until a constant ratio
between free and complexed met was attained. Then 1 eq. of 5′-GMP (final ratio of Pt:met:5′GMP = 1:1:3) was added. The complementary challenge reaction, addition of 1 eq of met to a
solution of the Pt(DNSH-dien)(5′-GMP) adduct, was also investigated (final ratio of Pt:met:5′GMP = 1:1:3). Competition Reactions. Solutions of Pt(DNSH-dien)Cl and [Pt(DNSHtren)Cl]Cl in D2O/DMSO-d6 (500 μL/100 μL) were treated with met and 5′-GMP at pH ~6.4
(Pt:met:5′-GMP = 1:1:3) and the reactions monitored by 1H NMR spectroscopy.
2.3 Results
2.3.1 NMR Characterization of Pt(II) Complexes
2.3.1.1 Pt(DNSH-dienH)Cl2 (1). Reaction of cis-Pt(Me2SO)2Cl2 with DNSH-dienH with
no added base affords Pt(DNSH-dienH)Cl2 (1) (Figure 2.2). Immediately upon dissolution of 1
in DMSO-d6, one major and one minor set of NH signals were observed. The minor set, which
disappeared after ~5 min but reappeared on addition of [Et4N]Cl (not shown), was assigned to 1,
and the major set was assigned to the solvolysis product, [Pt(DNSH-dienH)(Me2SO-d6)Cl]+ (114

sol), on the basis of its 195Pt NMR chemical shift (-3318 ppm), which was very similar to that of
[Pt(en)(Me2SO-d6)Cl]+ (-3307 ppm).23 NMR data are summarized in Table 2.1. The 1H NMR
aromatic signals of [Pt(DNSH-dienH)(Me2SO-d6)Cl]+ in DMSO-d6 (Figure 2.3) compared to
those of DNSH-dienH are not significantly affected by Pt binding to the DNSH-dienH ligand.
The 1H NMR NH signals of DNSH-dienH cannot be observed in DMSO-d6 unless DNO3 is
added. We attribute this result to fast NH exchange. However, once the ligand binds to Pt(II)
through N1 and N2 (for numbering, refer to Figure 2.1), the NH signals appear. We attribute this
result to slower NH exchange for the coordinated ligand.

Figure 2.3. Aromatic 1H NMR signals of the Pt(II) complexes formed by DNSH-dienH ligand;
in DMSO-d6, [Pt(DNSH-dienH)(Me2SO-d6)Cl]+ (1-sol), [Pt(DNSH-dien)(Me2SO-d6)]+ (2-sol),
Pt(DNS-dien) (4).
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Table 2.1. 1H NMR and 195Pt NMR Shifts (ppm) for Selected Ligands and Complexesa
Pt(II) complexc
ligandsb
DNSHdienH

DNSH
-tren

1

1-sol

2

2-sol
195

-3318

NMe2

2.83

2.82

N1H

3

4

5

5-sol

6

6-sol

-3235

-2634

-3364

-2721

-3465

Pt NMR

-2499

-3222

1

H NMR

2.83

2.83

2.82

2.82

2.81

2.71

2.82

2.82

5.23

6.15

5.11

5.97

5.14

5.42

5.37

6.31

5.43

6.55

5.29

6.34

5.32

5.53

5.66

5.95

5.51

6.66

6.61

7.89

6.64

5.72

7.34

8.39

5.34
N2H

6.27

6.98

N3H

8.05

8.22

8.24

8.26

H2

8.11

8.11

8.13

8.13

8.27

8.25

8.27

7.98

8.13

8.13

H3

7.59

7.59

7.61

7.61

7.47

7.61

7.44

7.22

7.65

7.65

H4

8.29

8.30

8.27

8.27

8.39

8.40

8.38

8.27

8.23

8.23

H6

7.25

7.25

7.25

7.25

7.15

7.24

7.17

6.81

7.26

7.26

H7

7.61

7.61

7.61

7.61

7.47

7.61

7.49

7.36

7.65

7.65

H8

8.46

8.45

8.48

8.48

8.60

8.50

8.62

8.48

8.48

10 mM, DMSO-d6, 25 °C. bChemical shifts of NH signals of protonated ligands, DNSH-dienH: 7.98 (N1H), 8.74 (N2H), 8.30
(N3H) and DNSH-tren: 8.01 (N1H), 8.37 (N3H). cPt(DNSH-dienH)Cl2 (1), [Pt(DNSH-dienH)(Me2SO-d6)Cl]+ (1-sol), Pt(DNSHdien)Cl (2), [Pt(DNSH-dien)(Me2SO-d6)]+ (2-sol), Pt(DNSH-dien)Br (3), Pt(DNS-dien) (4), [Pt(DNSH-tren)Cl]Cl (5), [Pt(DNSHtren)(Me2SO-d6)]2+ (5-sol), [Pt(dien)Cl]Cl (6), and [Pt(dien)(Me2SO-d6)]2+ (6-sol).
a
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The presence of the sulfonamide N3H signal (broad triplet, JH-H = 5.3 Hz) is an indication
that N1 and N2 participate in the binding to Pt(II) but N3 does not. For N3 to bind Pt(II), it must
be deprotonated. Thus, the NH signals of the DNSH-dienH ligand provide very useful
information for assessing the formation of the Pt(DNSH-dienH)Cl2 complex.
The combined use of 1H-1H COSY and ROESY NMR experiments allowed assignment
of all the aromatic signals. In particular, two sets of coupled signals have been identified from
the COSY spectrum, corresponding to the DNSH H2, H3, and H4 protons and H6, H7, and H8
protons (for numbering, refer to Figure 2.1). The ROESY cross-peaks between the
dimethylamino signal and two aromatic signals allowed identification of the H4 and H6 signals
and, from these, of the other signals. 1H-13C HMBC and HSQC NMR experiments were used for
13

C NMR signal assignment (Table 2.2). From the 1H-13C HSQC NMR experiment, the signals

of the carbons bearing a proton were identified easily because the proton spectrum was already
assigned. The HMBC cross-peak between the proton signal of the DNSH dimethylamino group
with the C5 signal was the key in assigning the rest of the peaks.
2.3.1.2 [Pt(DNSH-dien)(Me2SO-d6)]+ (2-sol). Soon after Pt(DNSH-dien)Cl (2) (Figure
2.2) was dissolved in DMSO-d6, two sets of 1H NMR signals were observed. After ~2 h one set
of signals disappeared. This set reappeared when [Et4N]Cl was added (not shown). The two sets
are thus clearly from the Pt(DNSH-dien)Cl complex (2) and the solvolysis product, [Pt(DNSHdien)(Me2SO-d6)]+ (2-sol). The latter predominates and is almost the exclusive species present in
the absence of added chloride salt. The data presented here are for [Pt(DNSH-dien)(Me2SO-d6)]+
(Figure 2.3). 1H and

13

C NMR spectral assignments, summarized in Tables 2.1 and 2.2, were

made in the same way as for [Pt(DNSH-dienH)(Me2SO-d6)Cl]+ (1-sol). The most significant
difference in the spectra of 2-sol (with a tridentate ligand) and 1-sol (with a bidentate ligand) is

17

the absence of the sulfonamide N3H signal for 2-sol. For the [Pt(DNSH-dien)(Me2SO-d6)]+
cation, the most upfield aromatic

13

C NMR signal is C6 (114.9 ppm). An H8-C6 cross-peak is

present in the HMBC spectra of [Pt(DNSH-dien)(Me2SO-d6)]+ and [Pt(DNSH-dienH)(Me2SOd6)Cl]+ (not shown). In aqueous/DMSO-d6 (500 μL/100 μL), 2 immediately gave evidence for a
solvolysis product; careful studies varying solvent composition indicate this species, which is
involved in the G/3′-IMP reactions and the 5′-GMP/met competition reactions, is [Pt(DNSHdien)(Me2SO-d6)]+ (2-sol). When 2-sol was heated at 70 °C for 14 h in D2O/DMSO-d6 (500
μL/100 μL) the H8 DNSH signal disappeared and H7 became a doublet; an incipient AB pattern
between H7 and H6 signals was observed. The fluorescence emission spectrum of 2-sol is less
intense than that of 1-sol, Figure 2.4.

Figure 2.4. Fluorescence emission spectra of the DNSH-dienH and DNSH-tren ligands and their
Pt(II) complexes.
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Table 2.2. 13C NMR Chemical Shifts (ppm) for [Pt(DNSH-dienH)(Me2SO-d6)Cl]+ (1-sol),
[Pt(DNSH-dien)(Me2SO-d6)]+ (2-sol), and Pt(DNS-dien) (4) Complexes in DMSO-d6 (10 mM,
25 °C)
Pt(II) complex
1-sol

2-sol

4

NMe2

45.1

45.1

45.3

C1

135.4

137.2

141.7

C2

127.9

127.0

121.6

C3

123.5

123.6

121.8

C4

129.0

129.1

126.3

C5

151.2

151.1

145.8

C6

115.2

114.9

114.0

C7

128.5

127.3

128.4

C8

119.0

119.9

126.8

C9

129.1

129.6

137.0

C10

129.8

128.3

128.9

2.3.1.3 Pt(DNS-dien) (4). This product (4), formed under the most basic conditions used,
has 5 of the 6 aromatic 1H NMR signals expected (Figure 2.3), providing evidence that 4 is
Pt(DNS-dien) (Figure 2.2). Two sets of coupled signals were identified by the COSY spectrum
(Figure 2.5A), corresponding to the DNS protons, H2, H3, and H4 of one ring, and H6 and H7 of
the ring containing the dimethylamino group. In the ROESY experiment (Figure 2.5B), crosspeaks were observed between the H7 signal and the two N1H signals of the dien moiety. Also,
the expected H6-H7, H2-H3, and H3-H4 cross-peaks were observed. All aromatic signals were
upfield (Table 2.1) compared to the corresponding signals of [Pt(DNSH-dien)(Me2SO-d6)]+ (2sol). Of note, the H7 signal is coupled to 195Pt (JPt-H = 22 Hz).
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1

H-13C HSQC and HMBC NMR experiments were used to assign the 13C NMR spectrum

(Table 2.2) and to confirm the structure of 4. For Pt(DNS-dien) three 1H-13C HMBC experiments
were carried out with different JH-C values (6.25, 8, and 10 Hz), but none of the spectra exhibited
an H8-C6 cross-peak as found in 1H-13C HMBC experiments (JH-C = 8 Hz) with [Pt(DNSHdien)(Me2SO-d6)]+ and [Pt(DNSH-dienH)(Me2SO-d6)Cl]+.

Figure 2.5. A 1H-1H COSY spectrum of Pt(DNS-dien) in DMSO-d6 at 298 K. B. 1H-1H ROESY
spectrum of Pt(DNS-dien) in DMSO-d6 at 298 K.
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2.3.1.4 [Pt(DNSH-tren)Cl]Cl (5). [Pt(DNSH-tren)Cl]Cl (5) (Figure 2.2) was prepared by
treating cis-Pt(Me2SO)2Cl2 with DNSH-tren. In DMSO-d6 the 1H NMR aromatic signals of the
DNSH group are not significantly affected by Pt binding (Table 2.1). Upon dissolution in
DMSO-d6 the signals of 5 decreased slightly and a downfield set of NH 1H NMR signals for
[Pt(DNSH-tren)(Me2SO-d6)]2+ (5-sol) increased. However, only ~10% of [Pt(DNSHtren)(Me2SO-d6)]2+ (5-sol) formed. In contrast, when 5 was dissolved in a mixture of
aqueous/DMSO-d6 (500 μL/100 μL, pH = 6.3), 5-sol formed to a much greater extent (~85%
after 2 hours). 5-sol was the reactive species present in the G/3′-IMP reactions and the 5′GMP/met competition reaction.
2.3.2 Pt(DNSH-dien)(G/3′-IMP) and Pt(DNSH-tren)(G/3′-IMP) Adducts
The solvent used for all adducts was D2O/DMSO-d6, 500 μL/100 μL, unless otherwise
specified. For low temperature experiments, the solvent mixture was D2O/DMSO-d6/methanol-d4
(500 μL/100 μL/100 μL).
2.3.2.1 Pt(DNSH-tren)(G/3′-IMP) (G = 3′-GMP, 5′-GMP). The Pt(DNSH-tren)(3′GMP) adduct (pH = 6.32) exhibited one H8 and one H1′ NMR signal downfield of the respective
signals of free 3′-GMP (Table 2.3). The aromatic signals of the DNSH group were not shifted by
3′-GMP binding (Table 2.4).
Results similar to those for Pt(DNSH-tren)(3′-GMP) were observed for the Pt(DNSHtren)(5′-GMP) adduct. For Pt(DNSH-tren)(3′-IMP), the resonances of both H8 and H2 shifted
downfield of the corresponding resonances of free 3′-IMP. Selected 1H NMR shifts for both free
and bound G/3′-IMP in Pt(DNSH-tren)(G/3′-IMP) adducts are listed in Table 2.3.
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Table 2.3. 1H NMR Chemical Shifts (ppm) for Pt(DNSH-dien)(G/3′-IMP) and Pt(DNSHtren)(G/3′-IMP) Adducts in D2O/DMSO-d6 500 μL/100 μL, 25 °C
G/3′IMP

pH

free H8
(H2)

H8
(H2)

free
H1'

H1'

Pt(DNSH-tren)(G/3′-IMP)
5'-GMP

6.32

8.09

8.61

5.89 5.96

3'-GMP

6.32

8.00

8.40

5.90 5.94

3′-IMP

6.26

8.38

8.83

6.12 6.17

(8.23)

(8.30)

Pt(DNSH-dien)(G/3′-IMP)
9-EtG

5.23

8.01

8.11

5'-GMP

5.21

8.11

8.27

5.87 5.69

8.25
3'-GMP

5.20

8.04

8.30

5.91 5.81

8.28
5'-GDP

5.25

8.14

8.30

5.90 5.69

8.28
5'-GTP

5.17

8.15

8.30

5.89 5.68

8.27
3'-IMP

5.23

8.39

8.72

(8.22)

(8.10)

6.13 6.01

8.69
(8.09)

2.3.2.2 Pt(DNSH-tren)(met-S)]2+. We studied the spectrum of the [Pt(DNSH-tren)(metS)]2+ adduct (pH = 6.4, at which met has a neutral overall charge), which exhibited a sharp
(FWHM = 3 Hz) S-methyl NMR signal (2.51 ppm) downfield of the S-methyl signal of free met
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(2.13 ppm). The α CH signal of [Pt(DNSH-tren)(met-S)]2+ was downfield (3.90 ppm) of that of
free met (3.82 ppm). The aromatic and the dimethylamino DNSH signals were not shifted.
Challenge Reaction. A few hours after addition of three equivalents of 5′-GMP to the solution
of the [Pt(DNSH-tren)(met-S)]2+ cation, the NMR signals of the bound met decreased, and
signals of the Pt(DNSH-tren)(5′-GMP) adduct appeared. After 20 and 40 days, respectively, the
Pt(DNSH-tren)(5′-GMP) to [Pt(DNSH-tren)(met-S)]2+product distribution was 70:30 and 100:0
(no signals for the met adduct remained). Competition Reaction. Figure 2.6 describes the time
course of the competition reaction of 5-sol with met and 5′-GMP (1:1:3). In the initial stages of
the competition reaction the peaks of free met decreased in size and the peaks of the [Pt(DNSHtren)(met-S)]2+ adduct appeared, while only a small amount of the Pt(DNSH-tren)(5′-GMP)
adduct was observed (Figure 2.6). In later stages the signals of [Pt(DNSH-tren)(met-S)]2+ began
decreasing and those of Pt(DNSH-tren)(5′-GMP) increased. Finally, after about two months,
only Pt(DNSH-tren)(5′-GMP) signals could be detected.

Figure 2.6. Time courses of competition reactions of [Pt(DNSH-tren)(Me2SO-d6)]2+ (5-sol) and
[Pt(DNSH-dien)(Me2SO-d6)]+ (2-sol) with met and 5′-GMP.
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2.3.2.3 [Pt(DNSH-dien)(9-EtG)]+. The [Pt(DNSH-dien)(9-EtG)]+ adduct (pH = 5.23),
prepared as described above, showed one set of 1H NMR signals. Compared to free 9-EtG, the
H8 signal was downfield (Table 2.3), but the CH3 and CH2 signals of the ethyl group were
shifted upfield to 1.17 from 1.48 ppm and to 3.92 from 4.11 ppm, respectively. The DNSH
signals of the adduct were upfield of the signals of [Pt(DNSH-dien)(Me2SO-d6)]+ (Table 2.4). A
spectrum recorded at -5 °C showed no broadening of the H8 signal.
2.3.2.4 Pt(DNSH-dien)(3′-GMP). For Pt(DNSH-dien)(3′-GMP) (pH = 5.20), two
aromatic singlets of similar intensity (Figure 2.7) integrate to a total of one proton. These singlets
appear downfield of the H8 signal of free 3′-GMP and are assigned to H8 of bound 3′-GMP by
two NOE cross-peaks to the H1′ signal.24 There was one H1′ signal for the adduct, upfield of the
H1′ signal of free 3′-GMP (Table 2.3). Also, only one set of DNSH aromatic signals was
observed, upfield of the corresponding signals of the starting complex (Table 2.4). Spectra were
also recorded from -5 °C to 65 °C in 5 °C intervals. The spectra recorded below 25 °C exhibited
two well-resolved 3′-GMP H8 signals, downfield from the H8 doublet for the DNSH group. In
spectra measured above 25 °C, these signals began to overlap because the DNSH H8 doublet
shifted downfield.

Also, the H2 doublet and H3 triplet of the DNSH group each shifted

downfield and in some cases the spectra indicated that these were in fact two very closely spaced
overlapping signals (of roughly equal size).
2.3.2.5 Pt(DNSH-dien)(G/3′-IMP) (G = 5′-GMP, 5′-GDP, 5′-GTP). The 1H NMR
spectra of the other Pt(DNSH-dien)(G) adducts were similar to that of Pt(DNSH-dien)(3′-GMP)
(Tables 2.3 and 2.4). The Pt(DNSH-dien)(3′-IMP) adduct gave two upfield-shifted H2 signals in
addition to the two downfield-shifted H8 signals and one upfield H1′signal, as observed for the
G adducts (Table 2.3).
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Table 2.4. 1H NMR Chemical Shifts (ppm) of the DNSH Moiety of ([Pt(DNSH-tren)(Me2SOd6)]2+ (5-sol), [Pt(DNSH-dien)(Me2SO-d6)]+ (2-sol), and Pt(DNSH-dien)(G/3′-IMP) in
D2O/DMSO-d6 (500 μL/100 μL)

DNSH

5-sol

Pt(DNSH-dien)(G/3′-IMP)

2-sol

signals

9-EtG

3'-GMP

5'-GMP

3'-IMP

pH

6.37

5.21

5.23

5.20

5.21

5.23

NMe2

2.92

2.94

2.94

2.93

2.94

2.93

H2

8.28

8.40

8.10

8.01

8.03

8.00

H3

7.74

7.78

7.48

7.48

7.48

7.45

H4

8.57

8.52

8.22

8.19

8.20

8.19

H6

7.49

7.49

7.43

7.43

7.45

7.54

H7

7.78

7.78

7.63

7.66

7.65

7.70

H8

8.32

8.67

8.30

8.27

8.26

8.27

2.3.2.6 Pt(DNSH-dien)(met-S). The [Pt(DNSH-dien)(met-S)]+ adduct in D2O/DMSO-d6
has a broad S-methyl signal (FWHM = 16 Hz, 2.49 ppm), which was downfield of this signal in
the spectrum of free met (2.18 ppm). Challenge Reaction. No replacement of the bound met or
bound 5′-GMP was observed even 60 days after addition of three equivalents of 5′-GMP to the
met adduct or one equivalent of met to the 5′-GMP adduct, respectively. Competition Reaction.
[Pt(DNSH-dien)(Me2SO-d6)]+ was treated with met and 5′-GMP (1:1:3). Roughly equal amounts
of [Pt(DNSH-dien)(met-S)]+ and Pt(DNSH-dien)(5′-GMP) were formed throughout the course of
the reaction (Figure 2.6).
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Figure 2.7. Aromatic region of the 1H NMR spectrum of the Pt(DNSH-dien)(3′-GMP) adduct.

2.4 Discussion
2.4.1 Pt(DNSH-dienH)Cl2 (1)
Under the least basic synthetic conditions used, cis-Pt(Me2SO)2Cl2 and DNSH-dienH
formed Pt(DNSH-dienH)Cl2, with DNSH-dienH acting as a bidentate ligand (central N2 and
terminal N1) (Figure 2.2). One key piece of evidence for this conclusion is the presence of the
sulfonamide N3H 1H NMR signal at a shift similar to that of the free DNSH-dienH ligand, as
expected for an unbound sulfonamide group because N3H must deprotonate prior to Pt binding.
Pt(en)Cl2 and Pt(N-Et-en)Cl2 (N-Et-en = N-ethylethylenediamine), when dissolved in DMSO-d6,
give the monosolvated species, in which only one Cl ligand is replaced by DMSO.23,25 1H NMR
data indicate that DMSO replaces one of the two chlorides of Pt(N-Et-en)Cl2 more readily than
the other one. The
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Pt NMR shifts for Pt(en)Cl2 and Pt(N-Et-en)Cl2 are -2345 and -2364 ppm,

respectively, whereas these are -3307 and -3325 ppm for [Pt(en)(Me2SO-d6)Cl]+ 23 and [Pt(N-Eten)(Me2SO-d6)Cl]+, respectively. [Pt(en)(Me2SO-d6)2]2+ has a 195Pt NMR chemical shift of -3650
ppm.23 The 195Pt NMR shifts of these monosolvated complexes are very close to the value (-3318
ppm) obtained for [Pt(DNSH-dienH)(Me2SO-d6)Cl]+, thus indicating that in DMSO-d6 only one
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Cl has been replaced to form [Pt(DNSH-dienH)(Me2SO-d6)Cl]+ (1-sol, Table 2.1). The
insignificant changes in the shifts of the DNSH 1H NMR signals and in fluorescence intensity
(see below and Figure 2.4) indicate that the DNSH moiety occupies a remote position relative to
the Pt.
2.4.2 Pt(DNSH-dien)X (X = Cl (2) or Br (3))
The key spectroscopic evidence that the DNSH-dienH ligand acts as a tridentate ligand in
Pt(DNSH-dien)X is the absence of the N3H signal indicative of a deprotonated sulfonamide N3,
a requirement for a sulfonamide to bind to metals. The Cl and Br ligands are readily displaced in
DMSO-d6 to give [Pt(DNSH-dien)(Me2SO-d6)]+ (2-sol). The behavior of Pt(DNSH-dien)X in
DMSO-d6 is similar to that of [Pt(dien)Cl]Cl.

Immediately after dissolution in DMSO-d6,

[Pt(dien)Cl]Cl showed two sets of NH NMR signals. The upfield set, assigned to [Pt(dien)Cl]+,
decreased with time, whereas the downfield set, assigned to [Pt(dien)(Me2SO-d6)]2+, increased
with time, and a ratio of ~1:1 was observed at equilibrium. The shifts of the central secondary
NH signals were more downfield than those of the terminal primary amines in both [Pt(dien)Cl]+
and [Pt(dien)(Me2SO-d6)]2+.26 The same trends were observed in the spectrum of Pt(DNSHdien)Cl in DMSO-d6, in which the NH signals of [Pt(DNSH-dien)(Me2SO-d6)]+ were downfield
of those of Pt(DNSH-dien)Cl, and the central N2H signal was downfield from the terminal N1H
signals. Comparing the chemical shifts of the NH signals, we observed that all NH signals were
shifted upfield for Pt(DNSH-dien)Cl relative to [Pt(dien)Cl]Cl (Table 2.1). The reason for the
upfield position of the shifts is undoubtedly the stronger electron donation to Pt(II) by a
sulfonamido group than by a terminal amine group.
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2.4.3 Pt(DNS-dien) (4)
The DNSH-dienH ligand can act as a quadridentate N3C ligand (terminal N1, central N2,
and sulfonamido N3 of the dien moiety and C8 of the DNS moiety), giving the chelate complex,
Pt(DNS-dien) (4) (Figure 2.2). The key evidence for C8 coordination was the missing H8 1H
NMR signal. The upfield-shifted positions of the aromatic and dimethylamino signals of the
DNS moiety of 4, vs. the corresponding signals of [Pt(DNSH-dien)(Me2SO-d6)]+ (2-sol), are also
consistent with the formation of a Pt−C8 bond. For example, the H7 signal moved upfield by
0.25 ppm. Furthermore, the coupling to
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Pt of the proton (H7) on the carbon adjacent to the

metallated carbon (C8) was 3JPt-H = 22 Hz. These results are comparable to those observed in
related Pt(II) complexes.27-29 For example, Carlone et al.29 found that in a Pt(II) complex with 3nitro-9-[(2-dialkylaminoethyl)amino]acridine attached by a Pt–C bond the resonance for the
proton adjacent to the Pt−C bond shifted upfield by 0.26 ppm and was coupled to
35 Hz).29 The C8

13

195

Pt (3JPt-H =

C NMR signal of 4 had shifted downfield from the free ligand signal after

formation of the Pt–C bond, as reported for other Pt(II) complexes with a Pt–C bond. (X-ray
structural analysis was also used to confirm the formation of the Pt−C bond in several cases).27,30
The N2H signal of the N3C complex is relatively upfield (by ~1.5 ppm) compared to complexes
having N,N,N coordination. We believe that this upfield shift is a result of the greater trans
influence (compared to a Cl or Me2SO-d6 ligand) of the negatively charged C8 atom trans to the
N2H.
2.4.4 [Pt(DNSH-tren)Cl]Cl (5)
This complex was designed to be a control, with the DNSH group remote from Pt. The
similarity of the DNSH signals to that of the free ligand and the presence of the sulfonamide NH
signal confirm that the desired structure formed. An unusual feature of this compound is that it
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did not readily undergo solvolysis in DMSO-d6 (~10% [Pt(DNSH-tren)(Me2SO-d6)]2+ (5-sol)
formed). The primary amine NH signals of 5 and 5-sol have shifts very similar to those of
[Pt(dien)Cl]Cl (6) and [Pt(dien)(Me2SO-d6)]2+ (6-sol), respectively. Upon dissolution in DMSOd6, 6 converted to an ~1:1 6:6-sol mixture. [Pt(N′-Me-dien)Cl]Cl was used as model for 5 and it
was found to undergo solvolysis by only ~15%. Thus, the presence of an alkyl group on the
central N decreases DMSO solvolysis. The shielding effect of Me2SO-d6 compared to Cl causes
~700 ppm upfield
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Pt NMR shifts of the Me2SO-d6 solvolysis product relative to the starting

[Pt(dien)Cl]+, [Pt(DNSH-tren)Cl]+, and Pt(DNSH-dien)Cl complexes in DMSO-d6.
2.4.5 Fluorescence Spectroscopy
The fluorescence intensity of N-dansyl-N'-ethylthiourea was quenched by 87% after
addition of Pt(II).31 This significant decrease was attributed to the “heavy atom effect.”31 The
presence of Pt(II) enhances the rate of the spin-forbidden process (S1 → T1).32-34 The
fluorescence intensity of the DNSH-tren ligand is decreased by only 20% on formation of
[Pt(DNSH-tren)(Me2SO)]2+ (Figure 2.4). We attribute the small degree of the decrease to the
remote position of the fluorophore from the Pt. Fluorescence spectra of [Pt(DNSHdienH)(Me2SO)Cl]+, [Pt(DNSH-dien)(Me2SO)]+, and Pt(DNS-dien) showed progressively more
significant quenching of the fluorescence intensity compared to that of the DNSH-dienH ligand
(Figure 2.4), probably due to the heavy atom effect33 of Pt(II). The greater quenching of the
fluorescence intensity as the hapticity of the DNSH-dienH ligand is associated with the increased
proximity of the dansyl group to the Pt. The high level of quenching of Pt(DNS-dien) relative to
[Pt(DNSH-dienH)(Me2SO)Cl]+ and [Pt(DNSH-dien)(Me2SO)]+ may also be attributed to the Pt–
C8 bond, which has changed the electronic properties of the fluorophore, in addition to the
heavy-atom effect.33,34 In the Pt(DNSH-dien)(5′-GMP) adduct, the observed additional
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quenching is attributed to efficient energy transfer from the naphthalene ring to the guanine
base.35 The insignificant additional quenching of the fluorescence intensity of Pt(DNSH-tren)(5′GMP) relative to that of [Pt(DNSH-tren)(Me2SO)]2+ (5-sol) is explained by the remote position
of the nucleotide relative to the fluorophore.

Figure 2.8. The two 6-oxopurine orientations for Pt complexes with dien-type ligands symmetric
about a plane perpendicular to the coordination plane and bisecting the ligand. For the two
possible rotamers of Pt(DNSH-tren)(G/3′-IMP) adducts: R is a sugar-phosphate; R′ = H (IMP) or
NH2 (GMP); R′′ = CH2CH2NHDNSH. For dien analogs, R′′ = H.

2.4.6 Pt(DNSH-tren)(G/3′-IMP) (G = 3′-GMP, 5′-GMP) adducts
The 6-oxopurine nucleobase of G/3′-IMP lies with its plane roughly perpendicular to the
Pt coordination plane. In a Pt(II) complex possessing a carrier ligand unsymmetrical with respect
to the coordination plane but symmetrical about a plane perpendicular to the coordination plane,
two 6-oxopurine orientations are possible (Figure 2.8), and hence two magnetically inequivalent
sets of signals are expected for slow rotation of the 6-oxopurine about the Pt–N7 bond. For
Pt(DNSH-tren)(G/3′-IMP) adducts, O6 can be on either the same or the opposite side of the
coordination plane as the CH2CH2NHDNSH substituent. In related cases with tridentate dientype ligands with both terminal nitrogens substituted, two downfield-shifted H8 signals
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indicating slow rotation of the two rotamers have been observed.11,12 The observation of only one
downfield-shifted H8 (and one H2 for 3′-IMP) signal and only one H1′ signal for each
Pt(DNSH-tren)(G/3′-IMP) adduct is attributed to nucleobase binding to Pt via N7 and to rapid
rotation around the Pt–N7 bond preventing the observation of separate signals for the two
rotamers. For Pt(dien)(G) adducts, fast rotation around the Pt–N7 bond is expected because both
terminal nitrogens are primary amino groups. Only one H8 signal was observed,36 as expected.
The aromatic signals of the DNSH group were unaffected by G/3′-IMP binding to [Pt(DNSHtren)(Me2SO-d6)]2+ (5-sol), most likely because the DNSH group is not close to the bound 6oxopurine base.
2.4.7 [Pt(DNSH-tren)(met-S)]2+ Adduct
The downfield shifts of the S-methyl and CH signals of met on binding to [Pt(DNSHtren)(Me2SO-d6)]2+ (5-sol) reported above are attributed to S binding to Pt. Similar shifts were
reported for [Pt(dien)(met-S)]2+.8,37 Thus, the adduct is [Pt(DNSH-tren)(met-S)]2+. Challenge
reaction. After addition of 5′-GMP to a [Pt(DNSH-tren)(met-S)]2+ solution, the met-S adduct
converted completely to the 5′-GMP adduct. This result was expected because the 5′-GMP
adduct is expected to be the thermodynamic product on the basis of challenge studies reported
for the [Pt(dien)(met-S)]2+ adduct.37 Competition reaction. Initially the [Pt(DNSH-tren)(metS)]2+ adduct formed to a much greater extent than the Pt(DNSH-tren)(5′-GMP) adduct in a
competition reaction of met and 5′-GMP for [Pt(DNSH-tren)(Me2SO-d6)]2+ (5-sol), indicating
that [Pt(DNSH-tren)(met-S)]2+ was the preferred kinetic product. With time, the N7-bound 5′GMP (thermodynamic) product formed (Figure 2.6), as found previously for the [Pt(dien)(metS)]2+ and [Pt(dien)(GSMe-S)]2+ adducts.6,8,37 At 40 h at the same pH (6.3) and same Pt(II):met:5′GMP ratio (1:1:3), 5-sol formed 55% of the met adduct, while [Pt(dien)(H2O)]2+ formed 42% of
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the met adduct.8 These results of intermolecular displacement support the previous findings that
the Pt−S (thioether) bond is the kinetically favored bond type, whereas the Pt−N7 bond is the
thermodynamically favored bond type.8 Because the dansyl fluorophore of 5-sol is positioned
away from the Pt(II) binding site, its presence did not affect the reactivity or selectivity toward
N-bearing (GMP) or S-bearing (met) biological targets of Pt(II).
2.4.8 Possible Rotamers for the Pt(DNSH-dien)(G/3′-IMP) Adducts
Although the central N2 is not substituted as in 5, the central N2H atom breaks the
symmetry of the Pt coordination plane in Pt(DNSH-dien)(G/3′-IMP) adducts. Therefore the
nucleobase, which is perpendicular to the plane, has two orientations (Figure 2.9). Also, the
DNSH group has two possible orientations, with the dimethylamino group on the same or the
opposite side of the coordination plane as the central N2H. Four rotamers are conceivable for the
Pt(DNSH-dien)(G/3′-IMP) adduct illustrated. However, the DNSH group normally exhibits fast
rotation around the C-sulfonamide bond,38 leading to averaging of the signals of the different
rotamers involving the DNSH group. Thus, for slow Pt–N7 rotation, two rotamers at most can be
detected on the NMR time scale for each of the two Pt(DNSH-dien) chiralities.
2.4.9 [Pt(DNSH-dien)(9-EtG)]+
[Pt(DNSH-dien)(9-EtG)]+ has only one 9-EtG H8 signal, which showed no broadening
even in a spectrum recorded at -5 °C, indicating that rotation around the Pt–N7 bond is too fast to
allow observation of separate signals for the two rotamers.39 Usually, when 9-EtG binds to Pt(II),
the Et group signals move downfield;40 the upfield-shifted Et signals of [Pt(DNSH-dien)(9EtG)]+ are undoubtedly due to the proximity of the 9-EtG to the anisotropic DNSH moiety.
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Figure 2.9. Two of the conceivable rotamers of Pt(DNSH-dien)(G/3′-IMP) complexes.
Rotamers illustrated have one of the conceivable DNSH orientations and two base orientations
with O6 on the same and the opposite side of the proton on the central N2. For 9-EtG (R = ethyl;
R′ = NH2), the mirror image of the adduct is an enantiomer. For nucleotides (R is a sugarphosphate and R′ = H (IMP) or NH2 (GMP)) the adducts with the mirror image of the Pt(DNSHdien) moiety are diastereoisomers of the rotamers shown.

Only one H8 signal was observed for the [Pt(DNSH-dien)(9-EtG)]+ adduct. For G
adducts, the presence of the sugar-phosphate group is known to slow rotation.12,39 Because the
rotation around the Pt–N7 bond in [Pt(DNSH-dien)(9-EtG)]+ could be faster than in nucleotide
adducts, we investigated Pt(DNSH-dien)(nucleotide) adducts to determine if the presence of the
bulky DNSH moiety on one side of Pt(II) binding site could slow the rotation enough to allow
the observation of H8 signals of more than one rotamer.
2.4.10 Pt(DNSH-dien)(G/3′-IMP) (G = 5′-GMP, 5′-GDP, 5′-GTP)
The results for these Pt(DNSH-dien) 6-oxopurine nucleotide adducts were similar, and
we shall refer mainly to the results obtained for the 3′-GMP adduct. Two H8 signals of
approximately equal intensity were observed at 25 °C, as expected if the adducts for each
Pt(DNSH-dien) chirality are formed to a comparable extent and if for each Pt(DNSH-dien)
chirality the two 6-oxopurine rotamers rotate rapidly on the NMR time scale about the Pt−N7
bond. A previous study of the Pt(N-Me3dien)(G) (G = 3′-GMP, 5′-GMP) adducts showed broad
peaks at room temperature, and low temperature was necessary for the rotation to be slow
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enough to give sharp NMR signals for the two rotamers.12 Apparently the presence of the bulkier
DNSH moiety on one side of Pt(II) binding site cannot slow the rotation enough to allow the
observation of more than one rotamer (for a 6-oxopurine nucleotide) at room temperature.
The aromatic DNSH and H1′ signals of the Pt(DNSH-dien)(3′-GMP) adduct shifted
upfield when compared to those of the starting [Pt(DNSH-dien)(Me2SO-d6)]+ complex and free
3′-GMP, respectively (Tables 2.3 and 2.4). These upfield shifts of the aromatic signals of the
DNSH group and of the H1′ signal upon adduct formation are consistent with the proximity of
the 3′-GMP to the DNSH group. On binding of the 6-oxopurine derivatives to Pt, the 3′-IMP H2
signals are shifted upfield (in contrast to the typical slight downfield shift), and the purine H8
signals are shifted downfield by about 0.3 ppm (an amount that is less than that for Pt(DNSHtren)(G/3′-IMP) (Table 2.3) and less than the typical 0.5 to 0.7 ppm).36,37

Figure 2.10. Proposed stacking interaction between the G/3′-IMP base and the DNSH moiety
viewed along (left) and from the top (right) of the coordination plane. The average separation of
the dansyl and the guanine planes is 3.6 Å.

The DNSH aromatic group is attached to the Pt(II) through a sulfonamido group, which
keeps the naphthalene ring in proximity to the nucleobase. The observation of the relatively
upfield shifts does not necessarily establish a stacking interaction (Figure 2.10). However, there
is evidence for purine-aromatic group stacking in Pt(DNSH-dien)(G) adducts. As the
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temperature was increased from below room temperature to 65 °C, the DNSH moiety signals
shifted downfield. This result is expected if the upfield shifting at low temperature is in part due
to stacking, because the average proximity of the two groups, which is fixed by the Pt−N bonds,
would not change with temperature in the absence of stacking at low temperature. When
Heetebrij et al.41 treated [Pt(en)(NH2(CH2)6NH-dinitrophenyl)Cl]Cl (a monofunctional complex)
with 5′-GMP, they observed that the dinitrophenyl group signals shifted upfield, which they
attributed to a stacking interaction between the guanine base of 5′-GMP and the dinitrophenyl
group. Stacking is possible because of the long, flexible (CH2)6 chain. Also, the 5′-GMP adduct
exhibited only one downfield 5′-GMP H8 signal, indicating rapid rotation about the Pt–N7 bond.
In this regard, this adduct is similar to the G adducts formed by [Pt(dien)Cl]Cl6,36,37 and by
Pt(DNSH-dien)Cl. The 5′-GMP H8 signal of the Pt(en)(NH2(CH2)6NH-dinitrophenyl)(5′-GMP)
adduct had a typical downfield shift. The aromatic group is attached by a flexible (CH2)6 chain
and apparently may not approach the purine base as closely as the dansyl group does in the
adducts reported here.
2.4.11 [Pt(DNSH-dien)(met-S)]+
The downfield shifts of the S-methyl signal of the [Pt(DNSH-dien)(met-S)]+ adduct are
attributed to binding of Pt(II) to the S of met.37 When met binds both through S and N, the rate of
inversion at S decreased enough that broadening can be observed in NMR spectra.42 A slightly
later report concluded that, in the [Pt(dien)(met-S)]2+ adduct, where met is bound only through S,
the inversion is fast on the NMR scale and therefore broadening of the S-methyl signal was not
observed.37 Our finding that the S-methyl signal for the [Pt(DNSH-tren)(met-S)]2+ adduct is
sharp appears to support this suggestion. However, if the S of the monodentate met of the
[Pt(DNSH-dien)(met-S)]+ adduct inverted rapidly, we should observe two sharp S-methyl
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signals, one for each Pt(DNSH-dien) chirality. If these signals overlapped, the overlapped signal
should be sharp. The broad S-methyl signal of the [Pt(DNSH-dien)(met-S)]+ adduct suggests a
possible alternative explanation for the sharp S-methyl signal of [Pt(dien)(met-S)]2+: the
difference in shifts for the two [Pt(dien)(met-S)]2+ diastereoisomers is too small to cause
broadening of the S-methyl signal. If this explanation holds, then the rate of inversion at S
cannot be assessed by 1H NMR methods when the two cis coordination environments are too
similar. Challenge Reactions. No replacement of the bound monodentate ligand was observed
after addition of 5′-GMP or met to a solution of the [Pt(DNSH-dien)(met-S)]+ or the Pt(DNSHdien)(5′-GMP) adduct, respectively. The presence of the Pt−sulfonamido bulky group close to
the binding site affected its selectivity toward N7 over sulfur binding. Competition Reaction.
No kinetic selectivity of [Pt(DNSH-dien)(Me2SO-d6)]+ (2-sol) toward met over 5′-GMP was
observed, and the ratio of the two adducts throughout the formation reaction was approximately
1:1 (Figure 2.6). In contrast, the competition reactions of [Pt(DNSH-tren)(Me2SO-d6)]2+ (5-sol)
(Figure 2.6) and [Pt(dien)Cl]Cl6,9,10 show preferential kinetic binding by met followed by
thermodynamic binding by 5′-GMP. The presence of a bulky group very close to the Pt(II)
binding site in 2-sol significantly affected the selectivity of Pt(II) toward met and 5′-GMP.
2.5 Conclusions
The DNSH-dienH ligand can act as a bidentate, tridentate, or quadridentate ligand. The
observation of only two H8 1H NMR signals for the Pt(DNSH-dien)(6-oxopurine nucleotide)
adducts indicates rapid rotation around the Pt−N7 bond. Thus, the addition of a bulky substituent
on just one terminal N of a dien-type ligand has been shown to be insufficient to slow the
rotation around the Pt−N7 bond. The upfield shifts of the signals of the DNSH group of all G/3′IMP adducts, the ethyl group of the 9-EtG adduct, and the H2 and H1′ of nucleotide adducts all
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indicate that the dansyl naphthalene group and the 6-oxopurine base are close and parallel. The
additional quenching found for the Pt(DNSH-dien)(5′-GMP) adduct can be attributed to energy
transfer, which is effective because of the close proximity of the dansyl group to the guanine
base.35 This quenching is avoided when the aromatic fluorophore is positioned remotely from
Pt(II), as exemplified by [Pt(DNSH-tren)Cl]Cl. This latter compound and [Pt(dien)Cl]Cl, which
have no substituents on the terminal amino groups to influence the approach of the incoming
monodentate ligand, have similar reactivity patterns toward 5′-GMP and met. The resulting
adducts and those derived from Pt(DNSH-dien)Cl exhibit similar dynamic properties. However,
the bulky dansyl group near the reaction site of Pt(DNSH-dien)Cl increases the reactivity toward
5′-GMP relative to that toward met. This effect could be explained by stacking between the
dansyl group and the guanine base of 5′-GMP.
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CHAPTER 3. fac-Re(CO)3L COMPLEXES CONTAINING TRIDENTATE
MONOANIONIC LIGANDS (L¯) WITH A SELDOM-STUDIED SULFONAMIDO
GROUP AS ONE TERMINAL LIGATING GROUP*
3.1 Introduction
Metal nuclide radiopharmaceuticals contain a metal core and an inner ligating unit,
usually having chelate rings. We refer to this part of the agent as a label, and important
properties of the label, which influence biological behavior, are charge and overall shape.
Technetium-99m (99mTc) is the most widely used diagnostic radionuclide in nuclear medicine.1-4
{99mTc(V)O}3+ has been the metal core used most predominantly, but recently the development
of the advantageous [99mTc(CO)3(H2O)3]+ precursor has opened new directions for
radiolabeling.5-7 Schibli et al. showed that agents with the fac-99mTc(I)(CO)3+ core bearing a
tridentate coordinated ligand are more robust and have better pharmacokinetic profiles than
agents

bearing

bidentate

ligands.8

Commonly

employed

chelating

ligands

(e.g.,

diethylenetriamine (dien),9 cysteine- and homocysteine-based ligands10,11) contain N, O, or S
donor atoms in groups such as carboxyls,12 amines,13-19 nitrogen heterocycles,14-16 and
thioethers.10,11,16,17
An important approach in the development of small (~5 kDa) metal nuclide
radiopharmaceuticals is the bioconjugation of a net neutral label to hormones, small peptides,
etc.20 For fac-99mTc(I)(CO)3+ agents, the ligand(s) occupying the three remaining coordination
sites must have one negative group close to the metal for net neutrality. A coordinated

*

Reproduced with permission from American Chemical Society: Christoforou, A. M., Fronczek,
F. R., Marzilli, P. A., Marzilli, L. G., "fac-Re(CO)3L Complexes Containing Tridentate
Monoanionic Ligands (L¯) with a Seldom-Studied Sulfonamido Group As One Terminal
Ligating Group" Inorganic Chemistry, 2007, in press. Unpublished work copyright 2007
American Chemical Society.
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carboxylate group provides such a unit, but it does not provide a point for ligand elaboration or
for bioconjugation. Consequently, there is a need to evaluate other groups within tridentate
monoanionic ligands. In this study, we explore ligands which provide one metal-bound negative
group and which offer a diverse chemistry, allowing bioconjugation via internal ligand atoms or
via a seldom-used negative terminal ligating group.21 We use ligands containing the sulfonamide
group, which has been shown to bind well to several metals

22-29

but Tc complexes with this

group have not been studied.
The non-radioactive fac-[Re(CO)3(H2O)3]+ analogue is useful in understanding the
chemistry of agents derived from the [99mTc(CO)3(H2O)3]+ species.10 As a prelude to
radiopharmaceutical studies, we analyzed a series of new Re(CO)3L complexes formed by
treating [fac-Re(CO)3(H2O)3]+ with four new ligands, LH, bearing a sulfonamide group (Figure
3.1). These ligands, tmbSO2-N,N-Me2dienH, tmbSO2-N′-MedienH, tmbSO2-dienH, and tmbSO2dipnH, bind in a tridentate fashion involving one nitrogen of a monoanionic deprotonated
sulfonamido group. The H’s in the ligand names (cf. caption of Figure 3.1) designate the
sulfonamide NH proton that is absent in the deprotonated bound ligand. We provide the first
detailed analysis of X-ray structures with a sulfonamido group bound to Re.
Given the promise of the

99m

Tc(CO)3L agents (L¯ = a facially coordinated tridentate

ligand), it is clearly important to understand how the ligand pucker depends on the various
components that can influence it (donor atoms, chains linking these atoms, exocyclic
substituents, etc.). Because the chelate ring atoms act as a fulcrum, the configuration of
asymmetric centers, the shape, and the conformation of the rings can have a large effect on the
overall shape of the agent, and hence on its biological activity.
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Figure 3.1. Ligands used in this study: N-[2-(2-dimethylaminoethylamino)-ethyl]-2,4,6trimethylbenzenesulfonamide (tmbSO2-N,N-Me2dienH); N-{2-[(2-aminoethyl)-methylamino]ethyl}-2,4,6-trimethylbenzenesulfonamide (tmbSO2-N′-MedienH); N-[2-(2-aminoethylamino)ethyl]-2,4,6-trimethylbenzenesulfonamide (tmbSO2-dienH); and N-[3-(3-aminopropylamino)propyl]-2,4,6-trimethylbenzenesulfonamide (tmbSO2-dipnH).

Although chelate ring pucker and factors affecting pucker have not been thoroughly
examined for radiopharmaceuticals, extensive structural information exists for a large number of
complexes with other metals containing chelate rings with an ethylene group bridge between
ligating atoms. Many of these structures have been analyzed by using principal component
analysis (pca) and other methods.30-37 When diethylenetriamine-type ligands bind to a metal
center in a tridentate fashion, the pucker of the two five-membered chelate rings can have either
δ or λ chirality (Chart 1), leading to four possible combinations of chelate ring chirality: δλ, λδ,
λλ, and δδ.
Chart 3.1

In pca studies on X-ray structures from the Cambridge Structural Database (CSD) of
[M(dien)2]n+ (M = Ni, Co, Zn, Cu, Cr, Rh, and Ir)31 and of [M(dien)Ln]32 complexes and M(dien)
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fragments30, the δλ and λδ conformation combinations were found much more frequently than
combinations with the same pucker chirality (δδ and λλ). On the other hand, Schmidtke and
Garthoff33 suggested that, because of steric effects of the hydrogen atoms of the ethylene chains,
fac coordination would favor a δδ or λλ combination. Thus, factors influencing pucker (which
in turn affect shape) are not well understood, and in a recent study, we found that the rings have
the same pucker in complexes of lanthionine (LANH2).11 The new Re(CO)3L complexes studied
here offer the opportunity to determine how widespread the occurrence of δλ and λλ
combinations is.
3.2 Experimental Section
3.2.1 Starting Materials
N,N-dimethyldiethylenetriamine (N,N-Me2dien) from Ames Laboratories, N-methyl-2,2′diaminodiethylamine (N′-Medien) from TCI America, and bis(3-aminopropyl)amine (dipn),
dien, 2-mesitylenesulfonyl chloride (tmbSO2Cl), dansyl chloride (DNS-Cl), and Re2(CO)10 from
Aldrich were all used as received. The DNS-dienH ligand (N-(2-((2-aminoethyl)amino)ethyl)-5(dimethylamino)naphthalene-1-sulfonamide)38

and

the

[Re(CO)3(H2O)3]OTf10

(OTf

=

trifluoromethanesulfonate) precursor were prepared by known methods.
3.2.2 Physical Measurements
1

H NMR spectra were recorded on either a 300 MHz or 400 MHz spectrometer. Peak

positions are relative to TMS or solvent residual peak, with TMS as reference. All NMR data
were processed with XWINNMR and Mestre-C software. IR spectra were recorded on a Bruker
TENSOR 37 spectrometer, and the values for the CO stretching frequencies are given in
Appendix B.39
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3.2.2.1 X-ray Data Collection and Structure Determination. All single crystals
suitable for X-ray crystallography were obtained by slow evaporation from acetone or methanol.
Single crystals were placed in a cooled nitrogen gas stream at ~100 K on a Nonius Kappa CCD
diffractometer fitted with an Oxford Cryostream cooler with graphite-monochromated Mo Kα
(0.71073 Å) radiation. Data reduction included absorption corrections by the multi-scan method,
with HKL SCALEPACK.40 All X-ray structures were determined by direct methods and
difference Fourier techniques and refined by full-matrix least squares techniques, by using
SHELXL97.41 All non-hydrogen atoms were refined anisotropically. All hydrogen atoms were
visible in difference maps, but were placed in idealized positions. One methyl group (C17) of 5
has its hydrogen atoms disordered into a "doughnut" of electron density, which was modeled as
six half-populated positions. A torsional parameter was refined for each methyl group. Mercury
Software was used as aid for measuring structural parameters.
3.2.3 Synthesis of Re(CO)3L
The crude ligands, LH, were synthesized by a slight modification of Krapcho’s method.42
A solution of the sulfonyl (tmbSO2Cl) or acetyl chloride (tmbCOCl) (~5 mmol, 100 mL of
dioxane) was added dropwise over the course of about 2 h to a solution of the amine (~50 mmol,
100 mL of dioxane). The reaction mixture was stirred at RT for 10 h. The dioxane was
completely removed under vacuum, and water (50 mL) was added. The product was extracted
into CH2Cl2 (2 × 100 mL), and the solvent was removed under rotary evaporation. The oil thus
obtained was used to synthesize the Re(CO)3L complexes as follows: an aqueous solution of
[Re(CO)3(H2O)3]+ (10 mL, 0.1 mmol) was treated with a methanol (1 mL) solution of the ligand
(0.1 mmol). The pH was adjusted to ~5 and the reaction mixture was heated at reflux for 10 h,
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then allowed to cool at RT, and the pH was increased to ~ 7. The resulting white solid that
precipitated was collected on a filter, washed with water, and dried under vacuum.
3.2.3.1 Re(CO)3(tmbSO2-N,N-Me2dien) (1). This general method just described, with
tmbSO2Cl (1 g) and N,N-Me2dien (6.5 mL), yielded the crude tmbSO2-N,N-Me2dienH ligand
(750 mg, 51% yield). 1H NMR (ppm) in CDCl3: 6.94 (s, 2H), 2.90 (t, 2H, CH2), 2.66 (t, 2H,
CH2), 2.64 (s, 6H, CH3), 2.55 (t, 2H, CH2), 2.33 (t, 2H, CH2), 2.29 (s, 3H, CH3), 2.20 (s, 6H,
NCH3). Treatment of [Re(CO)3(H2O)3]+ (0.1 mmol) with tmbSO2-N,N-Me2dienH (32 mg) as
described above afforded Re(CO)3(tmbSO2-N,N-Me2dien) as a white powder (26 mg, 44%
yield). Crystals obtained by slow evaporation from methanol were characterized by single-crystal
X-ray crystallography. 1H NMR (ppm) spectrum in acetone-d6: 6.91 (s, 2H), 6.17 (b, 1H, N2H),
3.54-3.10 (m, 6H, CH2), 3.10 (s, 6H, N-CH3), 2.70 (s, 6H, CH3), 2.59 (m, 2H, CH2), 2.24 (s, 3H,
CH3).
3.2.3.2 Re(CO)3(tmbSO2-N′-Medien) (2). The general method, with 1 g of tmbSO2Cl
and 6 mL of N′-Medien, afforded the crude tmbSO2-N′-MedienH ligand (650 mg, 48% yield). 1H
NMR (ppm) in CDCl3: 6.95 (s, 2H), 2.93 (t, 2H, CH2), 2.75 (t, 2H, CH2), 2.64 (s, 6H, CH3), 2.44
(t, 2H, CH2), 2.38 (t, 2H, CH2), 2.29 (s, 3H, CH3), 2.08 (s, 3H, N′-CH3). Treatment of
[Re(CO)3(H2O)3]+ (0.1 mmol) with tmbSO2-N′-MedienH (30 mg) as described above afforded
Re(CO)3(tmbSO2-N′-Medien) as a white powder (24 mg, 42% yield). Crystals obtained by slow
evaporation from acetone were characterized by single-crystal X-ray crystallography. 1H NMR
(ppm) spectrum in acetone-d6: 6.91 (s, 2H), 4.94 (b, 1H, N1H), 3.87 (b, 1H, N1H), 3.42-3.53 (m,
3H, CH2), 3.24 (s, 3H, N′-CH3), 3.01-3.18 (m, 5H, CH2), 2.64 (s, 6H, CH3), 2.24 (s, 3H, CH3).
3.2.3.3 Re(CO)3(tmbSO2-dien) (3). The general method, with tmbSO2Cl (1 g) and dien
(5.2 mL), yielded the crude tmbSO2-dienH ligand (600 mg, 54% yield). 1H NMR (ppm) in
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CDCl3: 6.93 (s, 2H), 2.92 (t, 2H, CH2), 2.73 (t, 2H, CH2), 2.67 (t, 2H, CH2), 2.63 (s, 6H, CH3),
2.59 (t, 2H, CH2), 2.28 (s, 3H, CH3). Treatment of [Re(CO)3(H2O)3]+ (0.1 mmol) with tmbSO2dienH (31.2 mg) as described above afforded Re(CO)3(tmbSO2-dien) as a white powder (21 mg,
38% yield). Crystals obtained by slow evaporation from methanol were characterized by singlecrystal X-ray crystallography. 1H NMR (ppm) spectrum in acetone-d6: 6.90 (s, 2H), 6.17 (b, 1H,
N2H), 4.75 (b, 1H, N1H), 3.98 (b, 1H, N1H), 3.36-3.00 (m, 8H, CH2), 2.65 (s, 6H, CH3), 2.24 (s,
3H, CH3).
3.2.3.4 Re(CO)3(tmbSO2-dipn) (5). The general method, with tmbSO2Cl (1 g) and dipn
(6 mL), produced the crude tmbSO2-dipnH ligand (600 mg, 42% yield). 1H NMR (ppm) in
CDCl3: 6.94 (s, 2H), 2.98 (t, 2H, CH2), 2.76 (t, 2H, CH2), 2.71 (t, 2H, CH2), 2.63 (t, 2H, CH2),
2.63 (s, 6H, CH3), 2.29 (s, 3H, CH3), 1.62 (m, 4H, CH2). Treatment of [Re(CO)3(H2O)3]+ (0.1
mmol) with tmbSO2-dipnH (32 mg) as described above afforded Re(CO)3(tmbSO2-dipn) as a
white powder (24 mg, 41% yield). Crystals obtained by slow evaporation from acetone were
characterized by single-crystal X-ray crystallography. 1H NMR (ppm) spectrum in acetone-d6:
6.93 (s, 2H), 5.20 (b, 1H, N2H), 4.64 (b, 1H, N1H), 3.98 (b, 1H, N1H), 3.46 (m, 2H, CH2), 3.28
(s, 2H, CH2), 3.10-3.19 (m, 3H, CH2), 3.94 (s, 2H, CH2), 2.66 (s, 6H, CH3), 2.25 (s, 3H, CH3),
1.90 (s, 2H, CH2), 1.66-1.75 (s, 2H, CH2).
3.3 Results and Discussion
In a modification of the method of Krapcho,42 monoaddition of the relatively large
hydrophobic aromatic tmbSO2 group to triamines produced hydrophobic ligands that were
readily extracted into CH2Cl2 from water (with the excess of unchanged triamine remaining in
the water layer). This method afforded a series of triamine ligand derivatives (LH) in sufficient
yield and purity for use in preparing Re complexes. These ligand derivatives bind to the fac-
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Re(I)(CO)3 center as tridentate deprotonated monoanionic ligands L¯, thereby forming
complexes with a neutral core.
3.3.1 X-Ray Characterization
Crystal data and structural refinement details are summarized in Table 3.1 for new
complexes and in Appendix B39 for the previously briefly described compound Re(CO)3(DNSdien), 4.43 All the complexes reported here have a distorted octahedral structure, with the three
carbonyl ligands coordinated facially (Figure 3.2). The remaining coordination sites are occupied
by two sp3 N amines and one sp2 N from a sulfonamido group.

Figure 3.2. Perspective drawings of the S configuration of Re(CO)3(tmbSO2-N,N-Me2dien) (1),
Re(CO)3(tmbSO2-N′-Medien) (2), Re(CO)3(tmbSO2-dien) (3), and Re(CO)3(tmbSO2-dipn) (5).
Thermal ellipsoids are drawn with 50% probability.
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Table 3.1. Crystal Data and Structural Refinement for Re(CO)3L Complexes in Which L¯
Contains a Sulfonamido Group
Re(CO)3L complex
1

2

3

C18H26N3O5ReS

C17H24N3O5ReS
•0.5H2O

C16H22N3O5ReS
•0.5CH3OH

C18H26N3O5ReS

582.68

577.66

570.65

582.68

monoclinic

monoclinic

triclinic

triclinic

C2/c

P2/c

P1

P1

a (Å)

38.994 (2)

15.945 (2)

7.6603 (5)

7.956 (3)

b (Å)

14.7085 (10)

10.9504 (15)

7.8808 (5)

11.833 (4)

c (Å)

14.6254 (10)

12.2394 (16)

16.6154 (12)

12.129 (4)

α (°)

90.0

90.0

98.181 (4)

115.71(2)

β (°)

94.642 (4)

100.451 (7)

95.974 (4)

94.66 (2)

γ (°)

90.0

90.0

98.736 (4)

98.50 (2)

V (Å3)

8360.8 (9)

2101.6 (5)

973.20 (11)

1003.9 (6)

T (K)

90

115

90

115

Z

16

4

2

2

ρcalc (g/cm3)

1.852

1.826

1.947

1.928

abs coeff (mm-1)

5.947

5.916

6.386

6.191

2θmax (°)

71.2

68.4

82.2

52

R indicesa

0.028

0.039

0.025

0.045

wR2 = [I>
2σ(I)]b

0.063

0.095

0.069

0.091

data/param

19029/516

7997/253

12822/257

3910/255

empirical
formula
fw
crystal
system
space group

5

unit cell dimensions

a

R = (∑||Fο| - |Fc||)/∑|Fο|; bwR2 = [∑[w(Fο2 - Fc2)2]/∑[w(Fο2)2]]1/2
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Table 3.2. Selected Bonded and Non-bonded Distances (Å) and Bond Angles (deg) for
Re(CO)3(tmbSO2-N,N-Me2dien) (1), Re(CO)3(tmbSO2-N′-Medien) (2), Re(CO)3(tmbSO2-dien)
(3), Re(CO)3(DNS-dien) (4), and Re(CO)3(tmbSO2-dipn) (5)
Re(CO)3L complex
1

2

3

4

5

bond distances
Re–N1

2.2873 (19)/2.2880 (19)

2.222 (4)

2.2247 (15)

2.204 (3)

2.209 (7)

Re–N2

2.2065 (19)/2.2156 (18)

2.232 (3)

2.2172 (15)

2.222 (3)

2.249 (7)

Re–N3

2.2022 (18)/2.2007 (17)

2.195 (3)

2.1898 (15)

2.166 (3)

2.197 (6)

bond angles
N1–Re–N2

78.87 (7)/78.15 (7)

78.79 (13)

78.24 (6)

77.48 (11)

86.4 (2)

N2–Re–N3

75.89 (7)/75.45 (7)

76.62 (12)

75.96 (5)

74.42 (12)

81.5 (2)

N1–Re–N3

86.79 (7)/86.75 (7)

84.06 (14)

84.06 (6)

82.77 (12)

84.7 (2)

N2–Re–C2

171.57 (9)/172.02 (8)

173.97 (18)

171.58 (7)

171.86 (13)

178.8 (3)

non-bonded distances
N1 to N2

2.855/2.839

2.826

2.803

2.769

3.051

N2 to N3

2.711/2.702

2.702

2.745

2.653

2.903

C4 to C7

3.258/3.234

3.169

3.206

3.907

C4H to C7H

2.156/2.112

1.991

2.027

3.927

C5 to C6

2.496/2.497

2.494

2.509

2.494

C5H to C6H

2.256/2.269

2.289

2.291

2.361

Typically, the Re−C(3) bond distances, involving the CO group trans to the sulfonamido
group, are not significantly different from those of the other Re−CO bonds. Although we found
that the aromatic rings facilitated our efforts to obtain crystals, these rings generally were not
stacked. The closest distance between carbons of two benzene rings (3.69 Å) was found for
Re(CO)3(tmbSO2-N,N-Me2dien) (1), in which the two carbons were in the two slightly different
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molecules of the asymmetric unit. This distance of 3.69 Å is too long to indicate stacking
interactions between the aromatic rings.
3.3.1.1 Bond Lengths and Hybridization. The average Re−N bond length of ~2.2 Å
(see Table 3.2 for selected bond lengths and angles of the sulfonamido complexes) found in the
sulfonamido complexes is consistent with distances found in relevant Re(CO)3 complexes
containing dien, such as [Re(CO)3(dien)]Br.9 The ~0.2 Å longer Re−N bonds in Re(CO)3L
compared to relevant Pt−N bonds (e.g., including terminal amines (2.063(9) and 2.063(10) Å,
and the secondary amine, 2.002(8) Å, of [Pt(dien)Cl]Cl44) are explained by the greater radius for
Re(I). The Re−N1 bond (to the terminal amine) in Re(CO)3(tmbSO2-N,N-Me2dien) (1) is
significantly longer than the other Re−N bonds in 1 and the other sulfonamido compounds 2-5.
This lengthening is attributed to the bulkiness of the two methyl groups on N1 (for 1) compared
to the smaller H group in all other sulfonamido compounds.
The sp2 N donors can form shorter Re−N bonds than can the sp3 N donors.14,45 Typical
Re−sp2 N bond lengths range from 2.14 to 2.18 Å, as measured in a number of Re structures
containing Re−N bonds (aromatic sp2 N, e.g., in pyridyl ligands), whereas a typical Re−sp3 N
bond length is ~2.2 Å.10,11,14 The sp2-hybridized N3 should affect the S−N3−C7, S−N3−Re, and
C7−N3−Re angles. However, although we have several structures to compare, the differences
between molecules were generally consistent with expectations for Re−sp2 N vs. Re−sp3 N
centers, but are small and thus are masked by steric and solid-state effects.
The N−SO2 bond lengths for the deprotonated sulfonamido group, between 1.561(3)1.5902(18) Å for complexes 1 to 5, are within the relatively broad range for N−SO2 bonds (1.51.7 Å) found in deprotonated sulfonamides bound to a metal (e.g., Cu, Zn, and Ni).22,24
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Figure 3.3. Absolute configuration. When the structure is viewed with the non-chelate ring
substituent on N2 projecting away from the viewer (left), the absolute configuration at N2 (left)
and Re (right) is designated to be S for a counterclockwise trace for the other N substituents (Re,
R1, and R2) according to higher priority as shown. When the trace is clockwise the absolute
configuration is R.

3.3.1.2 Bite Angles. The N1 to N2 and N2 to N3 distances within five-membered chelate
rings in the Re(CO)3L complexes have a narrow range of values (Table 3.2). The distances of
about 2.7 Å are similar to relevant distances in complexes with higher valent metal centers (e.g.,
Re(V) and Pt(II)) with shorter M−N bonds (~2 Å) (e.g., in [Pt(dien)Cl]Cl the N to N distances
average about 2.72 Å).44 The combination of the long Re−N bonds (compared to other M−N
bonds) and typical N to N distances results in more acute values for N−Re−N chelate ring bite
angles (less than 90°) and for trans N−Re−C angles (less than 180°) (see Table 3.2). For
complexes with five-membered rings (1-4), the N2−Re−N3 bite angle (N3 is part of the
sulfonamido group) is smaller (74.42°-76.62°) than the N1−Re−N2 bite angle (77.5°-78.9°).
These values are significantly smaller than the respective bite angles, 81.5° and 86.4°, in
Re(CO)3(tmbSO2-dipn) (5), as expected from the large six-membered rings in this complex.
Nevertheless, these angles for 5 are less than that (~89.5°) for Re(CO)3(N,N,N′,N′-tetramethyl1,3-propylenediamine)Br.46 Although the methyl groups cause the Re−N bonds to be very long
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(2.3 Å), the complex also has a very long N to N distance (3.25 Å), explaining the large bite
angle.
3.3.1.3 Chirality and Conformation of Chelate Rings. For 1, 2, and 3, the pucker of the
two chelate rings has different chirality. As mentioned, a different chirality for the pucker of
each dien chelate ring is found most often.30-32 Because the ligands in this study are
unsymmetrical, we report chirality combinations by giving the pucker chirality of the ring with
the terminal amine followed by that of the ring with the sulfonamido group. Also, we specify the
absolute configuration because the unsymmetrical nature of the ligand creates asymmetric
central nitrogen (N2) and Re centers. Specifically, this combination for 1-3 is λδ for the
enantiomer with the S absolute configuration (determined by the absolute configuration at N2,
Figure 3.3). In contrast, both chelate rings of Re(CO)3(DNS-dien) (4) have pucker with the same
chirality (both λ for the S configuration). This less-common situation with the same pucker
chirality for both rings also occurs in the Re(CO)3(LANH) complexes.11 Τhe meridionally
coordinated ligand in the pseudo square planar Pt(tmbSO2-N,N-Me2dien)Cl complex (work in
progress), has the δλ chirality combination (S absolute configuration at central N).
In an early study based on IR data, Schmidtke and Garthoff 33 determined that the δδ or
λλ combination was the most favorable for facial coordination of diethylenetriamine in
complexes of several metals (Cr, Co, Rh) and proposed that steric effects of the hydrogens of the
ethylene chain would also favor the δδ or λλ combination. We compared selected non-bonded
distances for 1-4 (Table 3.2) involving chelate ring carbons and hydrogens on these carbons
projecting toward the center of the triangular face occupied by L¯. Whether the pucker chirality
of the two chelate rings in a given complex is the same or different, the C5 to C6 (Figure 3.4)
and C5H to C6H distances are not very different. In contrast, when the chirality of the two
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chelate rings is the same, the C4 to C7 (Figure 3.4) and C4H to C7H distances are larger than
when the chirality is different. For example, the C4 to C7 distance for 4 (same chirality) is 3.9 Å,
whereas the respective distance for complexes 1-3 (different chirality) is ~ 2 Å.

Figure 3.4. Illustration of the shorter C4 to C7 non-bonded distances for complexes 1-3
(different pucker chirality) compared to complex 4 (same pucker chirality). Note the similarity of
the C5 to C6 non-bonded distances. Also shown are the position of C4 and C5 atoms relative to
N1−Re−N2 plane (red line), and C6 and C7 atoms relative to N2−Re−N3 (blue line) plane.
It is obvious from Figure 3.4 that the distance from C4 to C7 is much larger when the
pucker chirality is the same in both rings, as it is in complex 4, compared to when the chirality is
different. Our observations appear to support the early suggestion of Schmidtke and Garthoff,33
and the δδ and λλ combinations should be favored. However, later literature surveys31,32 find that
X-ray structures of complexes more frequently have different chirality in the two rings. In
particular, one pca study on X-ray structures from the Cambridge Structural Database (CSD)
showed that 74 fragments had the δλ chirality combination, 16 fragments had the λδ chirality
combination, 18 fragments had δδ and 18 enantiomeric fragments had the λλ chirality
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combination.30 This study agreed with earlier pca studies.31,32 This overwhelming evidence for a
predominance of structures with different pucker chirality is surprising, given that the distances
between hydrogens or carbons on the two rings (Table 3.2, Figure 3.4) are clearly shorter than
the sum of the van der Waals radii both for carbon (3.4 Å) and hydrogen (2.4 Å).47 This
proximity leads to steric repulsion between rings, as suggested by Schmidtke and Garthoff.33
Additional studies are needed to clarify factors influencing pucker, but at this time it seems
reasonable to assume in designing radiopharmaceuticals with the

99m

Tc(CO)3 label that the

pucker chirality of the rings will be different.
3.3.2 Solution Behavior
3.3.2.1 Trimethylbenzyl Group Rotation. In the X-ray structures of the tmbsulfonamido complexes (1, 2, 3, and 5) the 3 and 5 protons and the 2 and 6 methyl groups of the
tmbSO2 group are not equivalent. When modeling software is used to rotate the tmb group
around the S−C bond, beginning with the solid-state structure of 3, clashes are observed between
the methyl groups and a CH2 group of the chelate ring. For 3 the distance from C7 to C16 (of the
CH3 group in position 2) becomes as short as ~1.9 Å, much less than the sum of the van der
Waals radii for two carbons (3.4 Å).47 The resulting impediment to rotation about the S−C(tmb)
bond should lead to well separated 1H NMR signals. Indeed, in Re(CO)3(tmbCO-dien, (tmbCOdienH = N-[2-(2-aminoethylamino)-ethyl]-2,4,6-trimethylbenzamide, unpublished work), where
the tmb is linked through a deprotonated amido instead of a sulfonamido group, the 1H NMR
signals of the 3 and 5 protons and the 2 and 6 methyl groups of the tmbCO group are separate,
consistent with the expected slow rotation from a similar comparison using modeling software.
However, even at low temperature, these tmb 1H NMR signals are not resolved for the tmbsulfonamido complexes. (The 1H NMR spectrum of 1 (acetone-d6) recorded at -90 °C has no
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significant difference from the one recorded at 25 °C.) Further examination of the possible
rotations around the S−C and N3−S bonds in the tmb-sulfonamido complexes reveals that
concerted rotations about both these bonds can allow the tmb group to rotate more freely. In
particular, if the N3−S bond is rotated by ~56°, the tmb group can rotate freely around the
S−C(tmb) bond, and the closest distance between C7 and C16 (of the CH3 group in position 2) is
~ 3.2 Å; slight changes in bond angles should increase this distance.
The structures of 1-5 indicate considerable conformational freedom around the N−S
bond. In contrast, the N−C bond in the relatively planar amido group has more double bond
character than the N−S bond of the sulfonamido group. These features limit the CO group to
only two favorable orientations, and in both orientations serious clashes are observed when the
tmb group is rotated around the C−C(tmb) bond. In addition, the sulfonamido group has longer
bonds (N−S and S−C) compared to the respective bonds (N−C and C−C) of the amido group in
Re(CO)3(tmbCO-dien). Therefore, we believe that synchronous rotations about the longer N−S
and S−C bonds can explain the relatively free rotation of the tmb group, especially because the
sulfonamide group is known to be in relatively faster rotation than the amide group.48
3.3.2.2 NMR Characterization of Re(CO)3L (L¯ = tmbSO2-N,N-Me2dien¯, tmbSO2N′-Medien¯, tmbSO2-dien¯, DNS-dien¯ and tmbSO2-dipn¯). The Re(CO)3L complexes were
characterized by NMR spectroscopy (Table 3.3) in different solvents (DMSO-d6, and acetoned6). For a given solvent, the shifts of the respective N1H2 and N2H signals were similar in all
complexes reported here. For complexes 2-5 with a terminal amino group, the NH signals of this
group have a separation (Δ ppm) of between 1 to 2 ppm in DMSO-d6. In general, terminal amino
groups in Pt complexes have two separate signals with Δ ppm between 0.1 to 0.3.26 Specifically,
in DMSO-d6 the amino groups of 2-5 all have one downfield-shifted NH signal with a normal
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shift between 5.21 and 5.46 ppm, which is comparable to the shifts (5.11-5.66 ppm) of the
respective NH signals of the NH2 group in Pt(DNSH-dien)Cl and [Pt(dien)Cl]Cl.26 The upfieldshifted NH signal of 2-5 is between 3.30-3.59 ppm, which is ~1.5 ppm abnormally upfield
compared to the NH signals of Pt(II) complexes.

Table 3.3. Selected 1H NMR Chemical Shifts (ppm) of Re(CO)3(tmbSO2-N,N-Me2dien) (1),
Re(CO)3(tmbSO2-N′Medien) (2), Re(CO)3(tmbSO2-dien) (3), Re(CO)3(DNS-dien) (4), and
Re(CO)3(tmbSO2-dipn) (5)a
Re(CO)3L complex
1

2a

4a

3

5a

DMSO-d6
N1HB/Me

2.96

3.30

3.48

3.59

3.30

N1HA/Me

2.96

5.46

5.22

5.21

5.25

N2H

6.77

6.76

6.79

5.81

acetone-d6
N1HB/Me

3.10

3.87

3.98

4.09

4.00

N1HA/Me

3.11

4.94

4.75

4.77

4.66

N2H

6.17

6.17

6.23

5.20

a

Assignments of the NH signals of 2, 4 and 5 were made by analogy with signals for 3
assigned by COSY spectra.

An

1

H-1H COSY experiment for 3 in combination with torsion angles allowed

assignment of the NH signals. According to the Karplus equation,49 when the torsion angle
between two protons is 90°, no coupling is observed between the two protons (3J ≈ 0 Hz); a
maximum 3J is observed (3J ≈ 9.5 Hz) when the torsion angle is 180°. For Re(CO)3(tmbSO2dien)
(3), the NH2 signals are correlated by a COSY cross-peak. Also, the downfield N1H signal is
coupled to both C4H signals, whereas the upfield N1H signal is coupled to only one C4H signal.
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The H1B–N1–C4–H4B torsion angle is ~80° for 3, predicting a weak N1H1B-C4HB COSY
cross-peak, whereas the H1A–N1–C4–H4A torsion angle is~ 157° (close to 180°) for 3,
predicting a strong N1HA-C4HA COSY cross-peak. The H1B–N1–C4–H4A and H1A–N1–C4–
H4B torsion angles are both similar for both compounds and the N1HB-C4HA and N1HAC4HB cross-peaks were of similar size. Therefore, the downfield NH2 signal can be identified as
H1A (anti to the sulfonamido group) and the upfield NH2 signal as H1B. The reasons that the
NH1A signal for 2-5 has a normal shift and the N1HB signal has an unusually upfield shift are
unclear, and further investigation is required.
3.3.2.3 Reactions of Sulfonamido Complexes. Under neutral conditions (DMSO-d6/D2O
250 µL/550 µL, pH = 7.70) no change was observed in the 1H NMR signals of 3 even after 2
days. When a DMSO-d6 solution of 3 (3 mM) was made basic (dien, 10 equiv) no change was
observed in the 1H NMR signals of 3, even after the solution was heated at ~60 °C for 16 h.
Thus, 3 is stable under neutral and basic conditions, and a good ligand such as dien did not
replace the tmbSO2-dien ligand. Within minutes after the sulfonamido complex 3 (4 mM) was
dissolved under acidic conditions (DMSO-d6/1 M HNO3, 600 µL/20 µL, final [H+] = 0.3 M), the
1

H NMR spectrum was recorded. The sulfonamide NH signal appeared, (7.53 ppm), the N2H

signal shifted upfield (5.65 ppm), and the N1H signals moved downfield (5.41 and 4.08 ppm).
Similar results were observed when complex 5 was dissolved in the same acidic conditions; a
downfield sulfonamide signal appeared (7.76 ppm), the N2H signal (5.29 ppm) as well as the
N1H signal (5.03 ppm) shifted upfield, the second N1H signal was under the water signal. These
NMR data indicate that the sulfonamido nitrogen dissociates on protonation and the ligand is
now bound to the fac-Re(CO)3 moiety in a bidentate fashion through N1 and N2. Bidentate
binding for the DNS-dienH ligand has been reported in the Pt(DNS-dienH)Cl2 complex.26
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Comparisons of the 1H NMR spectrum for the latter complex to those obtained for 3 and 5 under
acidic conditions leave little doubt about the bidentate nature of the products. In these cases, the
signal of the central NH is substantially upfield in the bidentate ligand compared to the tridentate
ligand. A similar relationship of the NH shifts has been reported for Re(CO)3 complexes of an N3
ligand.
3.4 Conclusions
The tridentate monoanionic sulfonamido ligands studied here bind to the fac-Re(CO)3
core, giving an inner coordination sphere with a neutral charge. In strongly acidic conditions the
sulfonamido group dissociates with protonation, giving a monocationic inner coordination
sphere. The sulfonamido group in these complexes can act as a potential anchor for
bioconjugation, indicating that this class of tridentate ligands should be useful in the
development of radiopharmaceuticals with a

99m

Tc(CO)3 label. The dangling group connected

through the sulfonamido bond undergoes free rotation on the NMR time scale, even at low
temperature. Most complexes reported here have different chirality in each chelate ring, even
though less severe steric clashes are expected when both chelate rings have the same chirality.
We find in published and in our ongoing studies that the related amido complexes are much more
difficult to synthesize, consistent with the paucity of related amido complexes in the literature. In
contrast, the sulfonamido group has somewhat similar chemistry and more use of this group
should be made in coordination chemistry.
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CHAPTER 4. fac-[Re(CO)3L]+ COMPLEXES WITH N-CH2-CH2-X-CH2-CH2-N
TRIDENTATE LIGANDS. SYNTHETIC, X-RAY CRYSTALLOGRAPHIC AND NMR
SPECTROSCOPIC INVESTIGATIONS
4.1 Introduction
Radiopharmaceuticals based on the fac-[99mTc(CO)3]+ core are gaining extensive use
because the fac-[99mTc(CO)3(H2O)3]+ precursor can be conveniently generated.1-4 Agents with a
tridentately coordinated ligand (L) of the type, fac-[99mTc(CO)3L], are more robust and have
better pharmacokinetic profiles than agents bearing mono- or bidentate ligands.5 A recent
straightforward preparation of aqueous solutions of the non-radioactive fac-[Re(CO)3(H2O)3]+
precursor6 has made the synthesis of fac-[Re(CO)3L] analogues convenient and allows
simulation of the aqueous 99mTc synthetic chemistry.6,7 (Note: All specific complexes mentioned
in this work have a facial geometry; therefore the fac- designation is used henceforth only for
referring to a general class of compounds.) The most commonly employed L contain N, O, and S
as donor atoms from amine,8-10 pyridyl,11 carboxyl8 or thioether6,7 groups. Extensively
characterized fac-[Re(CO)3L] complexes of a series of symmetric and non-symmetric NNN or
NSN ligands containing combinations of amine, pyrazolyl, and thioether donors are known.12-14
During the development of radiopharmaceutical renal agents, polyamino-polycarboxylic acid
ligands have been investigated.8,15,16 At high pH amine group coordination is preferred, allowing
for dangling carboxyl groups, which are important in high renal clearance. Other studies
involving nitrogen, sulfur and oxygen donors have proposed that nitrogen donor ligands are
better than sulfur donor ligands for fac-[Re(CO)3L] complex formation.11,17
The location in space of the chelate ring atoms is a key factor in designing fac[99mTc(CO)3L] agents because these atoms act as a fulcrum for the pendant groups. In turn, the
position of the pendant group has a significant effect on the overall shape of the agent and hence
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on its biological activity. For diethylenetriamine-type ligands bound to a metal center in a
tridentate fashion, the pucker of the two five-membered chelate rings can have either δ or λ
chirality (Chart 1), leading to four possible combinations of chelate ring chirality: δλ, λδ, λλ,
and δδ. X-ray structures from the Cambridge Structural Database (CSD) of [M(dien)2]n+ (M =
Ni, Co, Zn, Cu, Cr, Rh, and Ir)18 and of [M(dien)Ln]19 complexes and M(dien) fragments20 were
analyzed by principal component analysis (pca) studies, and the δλ and λδ conformation
combinations were found more frequently than δδ and λλ combinations.

These results

contradicted the Schmidtke and Garthoff21 suggestion that a fac-coordinated dien favors a δδ or
λλ combination because of steric effects of the hydrogen atoms on the ethylene chains.
Chart 4.1

In a previous study10 we explored the chirality of the ligand pucker in a series of fac[Re(CO)3L] complexes with tridentate monoanionic ligands containing the diethylenetriamine
moiety and an aromatic group connected through a sulfonamide group, such as N-[2-(2aminoethylamino)ethyl]-2,4,6-trimethylbenzenesulfonamide (tmbSO2-dienH) (Chart 2). (The H
in the ligand names indicates the number of dissociable protons in the ligand and the complex.)
Our results showed that fac-coordinated sulfonamido ligands have different chirality in each
chelate ring more frequently than they have the same chirality, in agreement with the pca
reports.19,20 In contrast, the two chelate rings in the Re analogue of [99mTc(CO)3(LANH)] agents
(LANH2 = lanthionine, a natural dicysteine-derived dipeptide linked through a common sulfur
and exhibiting tridentate NSN binding) were found to have the same chirality.7 The 99mTc-tagged
lanthionine agents were the first small fac-[99mTc(CO)3L] agents reported to have been evaluated
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in humans;22 thus, additional studies directed at gaining a more comprehensive assessment of
conformation are warranted.
Chart 4.2

Normally the two protons of a primary amino group bound to a metal are magnetically
inequivalent and are expected to have two separate 1H NMR signals with similar shifts. The
similarity in shifts is understandable because the inductive effects of the surrounding atoms on
the amine nitrogen should be transmitted nearly equally to the protons. However, in several past
studies we found unusually upfield- and (in fewer cases) downfield-shifted NH signals for fac[Re(CO)3L] complexes with terminal amino groups, (e.g., fac-[Re(CO)3L] complexes of Smethyl-L-cysteine,6 methionine,6 chiral-LANH2,7 and sulfonamide ligands such as tmbSO2dienH),10 whereas in some other cases (e.g., fac-[Re(CO)3L] complexes of meso-LANH2 and
ethylenediamine-N-acetic acid, ENACH) the NH signals had similar shifts. The tridentate ligand
in [Re(CO)3(ENDAC)]- (ENDACH2 = ethylenediamine-N,N′-diacetic acid, Chart 2) binds
through a terminal amine group (NHCH2CO2-) and a secondary NH group anchoring two chelate
rings. Two isomers were crystallized, one with an endo-NH proton (pointing toward the carbonyl
groups) and the other with an exo-NH proton (pointing away from the carbonyl groups).8 In this
study, we have examined fac-[Re(CO)3L] complexes with less elaborate prototypical ligands,
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ones lacking large pendant substituents, in order to establish base-line behavior and thereby
define parameters useful for assessing the effects of the pendant groups. These unusual shifts
have led us to investigate the interaction of the complex with solvent as well as with the chloride
anion. Such an investigation can be viewed as creating a very preliminary set of empirical
observations relevant to the very difficult problem of predicting biodistribution, which is
influenced by interactions of the agent with the solvent and the anions present in the media.
4.2 Experimental Section
4.2.1 Starting Materials
Diethylenetriamine

(dien),

N,N′,N′′-trimethyldiethylenetriamine

(N,N′,N′′-Me3dien),

N,N,N′,N′′,N′′-pentamethyldiethylenetriamine (N,N,N′,N′′,N′′-Me5dien), and Re2(CO)10 from
Aldrich, N,N-dimethyldiethylenetriamine (N,N-Me2dien) from Ames Laboratories, and Nmethyl-2,2′-diaminodiethylamine (N′-Medien) and 2,2′-diaminodiethyl sulfide (daes) from TCI
America were all used as received. [Re(CO)3(H2O)3]OTf (OTf = trifluoromethanesulfonate)6 and
[Pt(dien)Cl]Cl23 were prepared by known methods.
4.2.2 Physical Measurements
4.2.2.1 NMR Spectroscopy. 1H NMR spectra were recorded on either a 300 MHz or 400
MHz spectrometer. Peak positions are relative to TMS or solvent residual peak, with TMS as
reference. All NMR data were processed with XWINNMR and Mestre-C software.
4.2.2.2 X-ray Data Collection and Structure Determination. Single crystals were
placed in a cooled nitrogen gas stream at ~100 K on a Nonius Kappa CCD diffractometer fitted
with an Oxford Cryostream cooler with graphite-monochromated Mo Kα (0.71073 Å) radiation.
Data reduction included absorption corrections by the multi-scan method, with HKL
SCALEPACK.24 All X-ray structures were determined by direct methods and difference Fourier
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techniques and refined by full-matrix least squares, using SHELXL97.25 All non-hydrogen atoms
were refined anisotropically. All hydrogen atoms were visible in difference maps, but were
placed in idealized positions. A torsional parameter was refined for each methyl group.
4.2.3 Synthesis of fac-[Re(CO)3L]+
4.2.3.1 fac-[Re(CO)3L]PF6 and fac-[Re(CO)3L]BF4. An aqueous solution of
[Re(CO)3(H2O)3]OTf (10 mL, 0.1 mmol) was treated with LH (0.1 mmol). The pH was adjusted
to ~6, and the reaction mixture was heated at reflux for 10 h. The reaction mixture was allowed
to cool to room temperature and the volume was reduced to 5 mL by rotary evaporation. Solid
NaPF6 or NaBF4 was added, and the white precipitate that formed was collected on a filter,
washed with ether, and dried under vacuum. X-ray quality crystals were obtained from the
filtrate or by slow evaporation from an acetone solution.
4.2.3.2 [Re(CO)3(dien)]PF6 (1a). Treatment of the [Re(CO)3(H2O)3]+ (0.1 mmol)
solution with dien (10 μL) as described above afforded [Re(CO)3(dien)]PF6 as a white powder
(10 mg, 27% yield) after the addition of NaPF6 (10 mg). The product was characterized by single
crystal X-ray crystallography. 1H NMR spectrum (ppm) in DMSO-d6: 6.98 (b, 1H, NH), 5.43 (b,
2H, NH), 4.13 (b, 2H, NH), 2.83 (m, 4H, CH2), 2.70 (m, 4H, CH2).
4.2.3.3 [Re(CO)3(dien)]BF4 (1b). Treatment of the [Re(CO)3(H2O)3]+ (0.1 mmol)
solution with dien (10 μL) as described above afforded [Re(CO)3(dien)]BF4 as a white powder (9
mg, 19% yield) after the addition of NaBF4 (10 mg). The product was characterized by single
crystal X-ray crystallography. 1H NMR spectrum (ppm) in DMSO-d6: identical to that of 1a.
4.2.3.4 [Re(CO)3(N′-Medien)]4(PF6)3(SO3CF3) (2). Treatment of the [Re(CO)3(H2O)3]+
(0.1 mmol) solution with N′-Medien (12 μL) as described above afforded [Re(CO)3(N′Medien)]PF6 as a white powder (17 mg, 44% yield) after the addition of NaPF6 (10 mg). The
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product was characterized by single crystal X-ray crystallography. 1H NMR (ppm) spectrum in
DMSO-d6: 5.59 (b, 2H, NH), 4.17 (b, 2H, NH), 3.13 (s, 3H, CH3), 3.08 (m, 2H, CH2), 2.92-2.66
(m, 6H, CH2).
4.2.3.5 [Re(CO)3(N,N-Me2dien)]PF6 (3). Treatment of the [Re(CO)3(H2O)3]+ (0.1
mmol) solution with N,N-Me2dien (13 μL) as described above afforded [Re(CO)3(N,NMe2dien)]PF6 as a white powder (15 mg, 38% yield) after the addition of NaPF6 (10 mg). The
product was characterized by single crystal X-ray crystallography. 1H NMR (ppm) spectrum in
DMSO-d6: 7.02 (b, 1H, NH), 5.68 (b, 1H, NH), 4.28 (b, 1H, NH), 3.06 (s, 3H, CH3), 2.95 (m,
4H, CH2), 2.76 (s, 3H, CH3), 2.75 (m, 4H, CH2).
4.2.3.5 meso-exo-[Re(CO)3(N,N′,N′′-Me3dien)]PF6 (meso-exo-4). Treatment of the
[Re(CO)3(H2O)3]+ (0.1 mmol) solution with N,N′,N′′-Me3dien (15 μL) as described above
afforded the meso-exo isomer of [Re(CO)3(N,N′N′′-Me3dien)]PF6 as colorless crystals (9 mg,
22% yield) after the addition of NaPF6 (10 mg). The product was characterized by single crystal
X-ray crystallography. 1H NMR (ppm) spectrum in DMSO-d6: 5.22 (b, 2H, NH), 3.18 (s, 3H,
CH3), 2.97 (m, 4H, CH2), 2.95 (d, 6H, CH3), 2.77 (m, 2H, CH2).
4.2.3.6 Solids with the [Re(CO)3(N,N,N′,N′′,N′′-Me5dien)]+ cation. Treatment of the
[Re(CO)3(H2O)3]+ (0.1 mmol) solution with N,N,N′,N′′,N′′-Me5dien (18 μL) as described above
followed by addition of NaBF4 (10 mg) or of NaPF6 (10 mg) afforded, respectively, colorless
crystals of [Re(CO)3(N,N′,N′,N′′,N′′-Me5dien)]OTf⋅[Re(CO)3(μ3-OH)4]⋅3.35H2O (5) from x-ray
(10 mg, 36% yield) and a white powder of [Re(CO)3(N,N′,N′,N′′,N′′-Me5dien)]PF6 (5a) (15 mg,
23% yield). 5a was recrystallized from acetone, and both crystal types were characterized by
single crystal X-ray crystallography. 1H NMR (ppm) spectrum of 5a in DMSO-d6: 3.23 (s, 6H,
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CH3), 3.21 (m, 4H, CH2), 3.19 (s, 3H, CH3), 3.06 (m, 2H, CH2), 2.93 (m, 2H, CH2), 2.81 (s, 6H,
CH3).
4.2.3.7 [Re(CO)3(daes)]PF6 (6). Treatment of the [Re(CO)3(H2O)3]+ (0.1 mmol) solution
with daes (10 μL) as described above afforded [Re(CO)3(daes)]PF6 as crystals (10 mg, 20%
yield) after the addition of NaPF6 (10 mg). The product was characterized by single crystal X-ray
crystallography. 1H NMR (ppm) spectrum in DMSO-d6: 5.55 (b, 2H, NH), 4.22 (b, 2H, NH),
2.94 (m, 2H, CH2), 2.75 (m, 6H, CH2).
4.3 Results and Discussion
4.3.1 X-Ray Characterization
All complexes exhibit a distorted octahedral structure, with the three carbonyl ligands
occupying one face. The remaining coordination sites are occupied by three amines for
complexes 1 to 5 (Figure 4.1) and two amine nitrogens and a thioether sulfur for 6 (Figure 4.2).
Crystal data and details of the structure refinement for complexes 1 to 6 are summarized in Table
4.1. The Re−N and Re−S bond lengths and the N−Re−N and S−Re−N angles (see Table 4.2 for
selected bond lengths and angles) are comparable to values of relevant complexes containing
amine and thioether groups.6,7,9,10 Because of the longer Re−S (~2.2 Å) and C−S (~1.8 Å) bonds
compared to the Re−N (~2 Å) and C−N (~1.4 Å) bonds, the S−Re−N chelate ring bite angles and
the N to S and C5 to C6 non-bonded distances are larger in 6 compared to the respective
parameters in 1 to 5, Table 4.3. However, near the terminal amines, the structure becomes more
similar for the NSN vs. the NNN compounds as illustrated in Appendix C. The implication of
this result is that pendant groups on terminal amines should project outward in a similar manner
for both types of chelates, whereas pendant groups on the carbons adjacent to the donor atom
anchoring the two chelate rings will project in a very different manner.
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Figure 4.1. Perspective drawings of [Re(CO)3(dien)]PF6 (1a), [Re(CO)3(dien)]BF4 (1b),
[Re(CO)3(N′-Medien)]4(PF6)3(SO3CF3) (2), [Re(CO)3(N,N-Me2dien)]PF6 (3), meso-exo[Re(CO)3(N,N′,N′′-Me3dien)]PF6
(meso-exo-4),
[Re(CO)3(N,N,N′,N′′,N′′Me5dien)]OTf⋅[Re(CO)3(µ3-OH)]4⋅3.35H2O (5) and [Re(CO)3(N,N,N′,N′′,N′′-Me5dien)]OTf (5a).
Counter ions are omitted for clarity. Thermal ellipsoids are drawn with 50% probability.

Figure 4.2. Perspective drawing of [Re(CO)3(daes)]PF6 (6). The counter ion is omitted for
clarity. Thermal ellipsoids are drawn with 50% probability.
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Table 4.1. Crystal Data and Structure Refinement for [Re(CO)3(dien)]PF6 (1a), [Re(CO)3(dien)]BF4 (1b), [Re(CO)3(N′Medien)]4(PF6)3(SO3CF3) (2), [Re(CO)3(N,N-Me2dien)]PF6 (3), meso-exo-[Re(CO)3(N,N′,N′′-Me3dien)]PF6 (meso-exo-4),
[Re(CO)3(N,N,N′,N′′,N′′-Me5dien)]OTf⋅[Re(CO)3(μ3-OH)]4⋅3.35H2O (5) and [Re(CO)3(daes)]PF6 (6)
1a
1b
2
3
meso-exo-4
5
6
formula

C7H13N3O3
RePF6

C7H13N3O3Re
BF4

4(C8H15N3O3Re
)(CF3O3S)(PF6)3

C9H17N3O3Re
PF6

C10H19N3O3ReP
F6

C12H23N3ReS(CF3
O3S)(C12H4O16Re4
)3.35(H2O)

C7H12N2O3
ReSPF6

518.37

460.21

2133.70

436.43

560.45

588.50

535.42

orthorhom
bic

monoclinic

monoclinic

orthorhombic

monoclinic

triclinic

orthorhombi
c

space group

Pna21

Cm

Pc

P212121

P21/c

P1

Pna21

a (Å)

16.396 (2)

9.566 (2)

11.4999 (6)

8.6289 (10)

14.6964 (15)

9.6358 (10)

12.3209 (12)

b (Å)

8.5554 (10)

10.267 (3)

11.6824 (9)

12.0976 (13)

13.2755 (12)

15.0396 (15)

8.3770 (10)

c (Å)

9.7512 (12)

8.010 (2)

22.8706 (15)

15.363 (2)

17.146 (2)

15.4932 (15)

14.1136.7 (3)

β (°)

90

125.730 (11)

90.145 (4)

90

91.165 (4)

98.815 (5)

90

V (Å )

1367.8 (3)

638.6 (3)

3072.6 (3)

1603.7 (3)

3344.5 (6)

2208.2 (4)

1456.7 (3)

T (K)

90

173

90

90

90

90

90

4

2

2

4

8

2

4

ρcalc (mg/m )

2.517

2.393

2.306

2.263

2.226

2.710

2.441

abs
coeff
-1
(mm )

9.084

9.570

8.096

7.754

7.440

13.80

8.670

2θmax (°)

72.8

73.6

71.2

80.4

74.0

37.4

73.6

R indicesa

0.027

0.047

0.036

0.048

0.042

0.036

0.054

wR2 = [I>
2σ(I)]b

0.063

0.063

0.083

0.057

0.092

0.087

0.072

15639/452

16677/570

6569/192

fw
crystal
system

3

Z
3

data/param
6131/192
2578/99
26464/804
9946/221
2
2 2
2 2 1/2
a
b
R = (∑||Fο| - |Fc||)/∑|Fο|; wR2 = [∑[w(Fο - Fc ) ]/∑[w(Fο ) ]]
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Table 4.2. Selected Bond Distances (Å) and Angles (deg) for [Re(CO)3(dien)]PF6 (1a), [Re(CO)3(dien)]BF4 (1b), [Re(CO)3(N′Medien)]4(PF6)3(SO3CF3) (2), [Re(CO)3(N,N-Me2dien)]PF6 (3), meso-exo-[Re(CO)3(N,N′,N′′-Me3dien)]PF6 (meso-exo-4),
[Re(CO)3(N,N,N′,N′′,N′′-Me5dien)]OTf⋅[Re(CO)3(μ3-OH)]4⋅3.35H2O (5) and [Re(CO)3(daes)]PF6 (6)a
1a

1b

2

3

meso-exo-4

5

6a

bond distances
Re–N1

2.238 (3)

2.213 (8)

2.197 (5)

2.240 (2)

2.233 (3)

2.233 (5)

2.243 (5)

Re–N2

2.201 (3)

2.222 (8)

2.250 (4)

2.205 (2)

2.238 (3)

2.230 (4)

2.4737 (10)a

Re–N3

2.244 (3)

2.215 (5)

2.265 (2)

2.220 (3)

2.295 (4)

2.226 (3)a

bond angles

a

N1–Re–N2

77.50 (12)

77.9 (3)

78.84 (18)

77.28 (9)

79.62 (13)

78.93 (16)

80.15 (9)a

N2–Re–N3

76.56 (12)

77.9 (3)

77.20 (17)

78.65 (9)

77.91 (13)

79.38 (15)

81.06 (12)a

N1–Re–N3

87.14 (12)

87.6 (6)

87.8 (2)

91.21 (9)

86.70 (14)

99.15 (16)

85.7 (2)a

For 6, parameters involving S and N2 are placed in the rows containing N2 and N3 values, respectively.
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The length of the Re−N bonds depends on the number and size of the substituents
replacing the ligand NH groups. The Re−N bonds in complexes in which N1 and N3 have two
methyl substituents (3 and 5) are significantly longer than any of the other Re−N bonds in 1 to 4,
in which N1, N2 and N3 have at most one methyl substituent replacing an H atom. This
lengthening is attributed to the bulkiness of the methyl groups compared to the smaller H group.
When the amine group has only one methyl group as a substituent, the Re−NHCH3 bonds are
numerically but not significantly longer than the Re−NH2 bonds. For both the endo and exo
Re(CO)3(ENDACH)

complexes

(which

crystallize

as

neutral

complexes),8

the

Re−NHCH2COOH bonds are significantly longer than the Re−NH2 bond of Re(CO)3(ENAC)8
and the Re−NH2 bonds of the complexes presented here. It is evident that a single methyl group
substituent on an amine group probably does not have enough bulk to cause significant
lengthening

of

Re−N

bonds,

whereas

larger

substituents

(e.g.,

CH2COOH

in

Re(CO)3(ENDACH) in the solid state) or two substituents (e.g., two methyl groups in 3 and 5)
have sufficient bulk to make the Re−N bonds significantly longer.
In the solid state of 1b and 6, intermolecular hydrogen bonding is observed between the
N2H or N1H2 (cf. Figures 4.1 and 4.2 for numbering) and a carbonyl group of another molecule
in the unit cell (N to O distance = 3.03 Å for 1b and 2.96 Å for 6). In complex 2, hydrogen
bonding is observed between the N1H2 group and the OTf counter ion (N to O distance = 2.87
Å). No hydrogen bonding was observed in the solid-state structures of 1a, 3, 4 and 5. In the
[Re(CO)3(dien)]Br crystal, intermolecular hydrogen bonding was observed between one Br¯
counter anion and a terminal NH2 group and a central NH of two separate cations.9
4.3.1.1 [Re(CO)3(dien)]X. The [Re(CO)3(dien)]Br salt just mentioned was prepared from
(NEt4)2[ReBr3(CO)3];9 however, because [Re(CO)3(dien)]+ serves as an important prototypical
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model complex for elaborated tridentate amine ligands, we synthesized the [Re(CO)3(dien)]+
complex by using [Re(CO)3(H2O)3]OTf as a precursor and crystallized both the PF6¯ (1a) and
the BF4¯ (1b) salts. The dien ligand has different chirality in each chelate ring of
[Re(CO)3(dien)]Br and [Re(CO)3(dien)]BF4, but the same chirality in [Re(CO)3(dien)]PF6. The
crystal structure of [Re(CO)3(dien)]Br contains two similar but independent cations in the
asymmetric unit. Overlaying of these two cations with [Re(CO)3(dien)]BF4 (1b) gave RMS =
0.0101 and 0.0125 (from overlaying the Re, N1, N2, and N3 atoms). In contrast, overlaying of
these two cations with [Re(CO)3(dien)]PF6 (1a) gave RMS = 0.0384 and 0.0378. The fit between
1a and [Re(CO)3(dien)]Br seems to be less good than that of 1b and [Re(CO)3(dien)]Br; such a
finding can be explained because the chirality of the pucker of the two chelate rings is different
in [Re(CO)3(dien)]Br and 1b, whereas the chirality of the pucker of the two chelate rings is the
same in [Re(CO)3(dien)]PF6 (1a).

Figure 4.4. Designation of rings A and B when the structure shown in the ORTEP is viewed
with the non-chelate ring substituent on N2 projecting away from the viewer. Also depicted are
the endo-NH protons (pointing toward the carbonyl groups) and the exo-NH protons (pointing
away from the carbonyl groups).
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4.3.1.2 Solids with the [Re(CO)3(N,N,N′,N′′,N′′-Me5dien)]+ Cation. The structure of
the [Re(CO)3(N,N,N′,N′′,N′′-Me5dien)]PF6 (5a) salt was disordered and did not allow analysis of
the chirality of the chelate rings. Therefore, we chose to report the crystallographic data and to
seek another salt for obtaining information on chelate ring pucker. We isolated and characterized
[Re(CO)3(N,N,N′,N′′,N′′-Me5dien)]OTf⋅[Re(CO)3(µ3-OH)]4⋅3.35H2O (5). The [Re(CO)3(µ3OH)]4 cubane-type cluster is well known to form in solutions of [Re(CO)3(H2O)3]+ at high pH.26
In the unit cell, the carbonyl groups of the [Re(CO)3(N,N,N′,N′′,N′′-Me5dien)]+ cation are
oriented toward the carbonyl groups of one of the Re atoms of the cluster with O to O nonbonding distances as close as 3.101 Å (Figure 4.3). The CSD contains many examples of this
cluster but none have a co-crystallized Re(I) complex.

Figure 4.3. View of the relative orientations of the [Re(CO)3(N,N,N′,N′′,N′′-Me5dien)]+ cation
and the neutral [Re(CO)3(µ3-OH)]4 molecule in the crystal of 5, showing the interactions of the
CO ligands depicted in the space filling-mode.

4.3.1.3 Chirality and Conformation of Chelate Rings. The two rings formed upon dien
binding are designated as A (left ring) and B (right ring) in Figure 4.4. Throughout the text and
in Table 4.3 we report chirality combinations by giving the pucker chirality of ring A followed
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by that of ring B for the ORTEP structures shown in Figure 4.1. The two chelate ring puckers of
2 to 6 have the same chirality, as found for 1a. Thus, only the 1b structure has different pucker
chirality in each of the two chelate rings, which is the combination most commonly observed.
The case of both rings having the same pucker chirality was observed in the [Re(CO)3(mesoLANH)] and [Re(CO)3(chiral-LANH)] complexes7 and in the sulfonamido [Re(CO)3(DNSHdien)]

complex

(DNSH-dienH

=

N-(2-((2-aminoethyl)amino)ethyl)-5-

(dimethylamino)naphthalene-1-sulfonamide).10 Τhe meridionally coordinated ligand in the
pseudo square planar complex, [Pt(dien)Cl]Cl,27 has the λδ chirality combination. It is obvious
from Table 4.3 that the distance from C4 to C7 is much larger when the pucker chirality is the
same in both rings, as it is in complexes 1a and 2 to 6, compared to when the ring chirality is
different, as it is in 1b and [Re(CO)3(dien)]Br. The distances between hydrogens or carbons on
the two rings when the rings have the same chirality are shorter than the sum of the van der
Waals radii for both carbon (3.4 Å) and hydrogen (2.4 Å).28 This proximity should cause steric
repulsion between rings, as suggested by Schmidtke and Garthoff,21 and their suggestion that the
δδ and λλ combinations should be favored in fac coordination of the dien ligand seems to be
supported by our observation. However, pca analyses of X-ray structures of complexes18,19 find
that complexes have different chirality in the two rings more frequently. These analyses were
supported by a more recent pca study20 showing that 74 fragments had the δλ chirality
combination, 16 fragments had the λδ chirality combination, 18 fragments had δδ and 18
enantiomeric fragments had the λλ chirality combination.
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Table 4.3. Selected non-bonded distances (ppm) for [Re(CO)3(dien)]PF6 (1a),
[Re(CO)3(dien)]BF4 (1b) [Re(CO)3(N′-Medien)]4(PF6)3(SO3CF3) (2), [Re(CO)3(N,NMe2dien)]PF6
(3),
meso-exo-[Re(CO)3(N,N′,N′′-Me3dien)]PF6
(meso-exo-4),
[Re(CO)3(N,N,N′,N′′,N′′-Me5dien)]OTf⋅[Re(CO)3(μ3-OH)]4⋅3.35H2O
(5)
and
[Re(CO)3(daes)]PF6 (6)
Complex

Pucker

C5HC6H

C5-C6

C4H-C7H

C4-C7

N1-N2
or N1-S

N2-N3 or
N2-S

[Re(CO)3(dien)]Br

λδ

2.290

2.514

2.119

3.279

2.790

2.788

1a

λλ

2.389

2.478

4.009

3.963

2.754

2.780

1b

λδ

2.296

2.524

2.080

3.281

2.787

2

δδ

2.487

2.461

4.272

3.999

2.812

2.797

3

λλ

2.485

2.493

4.153

4.029

2.775

2.833

meso-exo-4

λλ

2.419

2.458

4.011

3.937

2.840

2.826

5

δδ

2.390

2.459

4.128

4.054

2.890

2.902

6

λλ

2.616

2.683

3.945

4.010

3.070

3.032

4.3.1.4 [Re(CO)3(N,N′,N′′-Me3dien)]+ Isomers. Three [Re(CO)3(N,N′,N′′-Me3dien)]+
isomers are conceivable (Figure 4.4). The protons on the terminal amines can be endo (near the
carbonyl ligands in the basal plane) or exo (away from the carbonyl ligands), giving the mesoendo isomer (in which both protons point near the carbonyl ligands), the chiral isomer (in which
one methyl group points toward and the other away from the carbonyl ligands), and the meso-exo
isomer (in which both protons point away from the carbonyl ligands). The synthesis afforded a
mixture of the meso-exo (meso-exo-4) and the chiral (chiral-4) isomers, but only the meso-exo
isomer was isolated in crystalline form and characterized by X-ray crystallography.
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meso-exo

chiral

meso-endo

Figure 4.4. Possible isomers for [Re(CO)3(N,N′,N′′-Me3dien)]+.

4.3.2 NMR Spectroscopy
The [Re(CO)3L]+ complexes reported here were characterized by NMR spectroscopy
(Table 4.4) in different solvents (DMSO-d6, acetone-d6, acetonitrile-d3). For a given solvent, the
shifts of the respective terminal NH2 and central NH signals were similar for all of these
complexes. For complexes with terminal primary amino groups (1, 2, 3, and the previously
reported [Re(CO)3(DNSH-dien)]10), the NH signals of this group have a chemical shift
separation (Δ ppm) of 1 to 1.5 ppm in DMSO-d6. This separation is caused primarily by the fact
that one of the NH signals is unusually upfield. The [Re(CO)3(chiral-LANH)] complex has two
NH2 groups; one group has NH signals with normal chemical shifts of 5.44 and 5.10 ppm (Δ
ppm = 0.34) (similar to those of the [Re(CO)3(meso-LANH)] complexes), whereas the other NH2
group has one unusually upfield (3.92 ppm) and one downfield (6.19 ppm) NH signal (Δ ppm =
2.2). In general, terminal amino groups in Pt and Pd complexes have two signals with a Δ ppm
ranging from 0.1 to 0.4.29,30 Thus, in DMSO-d6 the relatively downfield NH signal of the amino
groups of 1 to 3 all fall in a normal shift range between 5.43 and 5.68 ppm, which is comparable
to the shifts (5.11 to 5.66 ppm) of the respective NH signals of the NH2 groups in [Pt(DNSHdien)Cl] and [Pt(dien)Cl]Cl.29 Complexes 3 and 5, which contain a dimethylamino group, have

77

two methyl signals with a separation of ~0.3 to 0.5 ppm in DMSO-d6. In acetone-d6 the
separation of the methyl signals of 5 is 0.36 ppm, and both the chemical shift and the separation
of the two methyl signals of the Me5dien ligand were comparable to those of the
[Pt(Me5dien)I]2Pt2I6 complex (Δ ppm = 0.17 ppm).31 The upfield shift effect appears to be
generally limited to a particular type of NH group.

Table 4.4. Selected Chemical Shifts (ppm) for [Re(CO)3(dien)]+ (1), [Re(CO)3(N′Medien)]4(PF6)3(SO3CF3) (2), [Re(CO)3(N,N-Me2dien)]PF6 (3), meso-exo-[Re(CO)3(N,N′,N′′Me3dien)]PF6
(meso-exo-4),
chiral-[Re(CO)3(N,N′,N′′-Me3dien)]PF6
(chiral-4),
[Re(CO)3(N,N,N′,N′′,N′′-Me5dien)]PF6 (5a) and [Re(CO)3(daes)]PF6 (6) in various solvents
fac-[Re(CO)3L]+ complex
dien

N′Medien

N,NMe2dien

N,N′,N′′Me3dien
chiral

N,N′,N′′Me3dien
meso-exo

N,N,N′,N′′,N′′
-Me5dien

daes

exo-N1H/Me

4.14

4.17

4.28/2.76

5.15/2.66

5.15

2.82

4.22

endo-N1H/Me

5.43

5.59

5.68/3.06

6.39/2.94

2.94

3.23

5.54

N2H/Me

6.98

3.13

7.02

3.15

3.18

3.19

exo-N1H/Me

4.40

4.37

4.27/3.01

4.74/2.99

5.02

3.08

4.41

endo-N1H/Me

5.22

5.42

5.54/3.30

6.03/3.21

3.21

3.44

5.43

N2H/Me

6.57

3.39

6.64

3.40

3.44

3.43

exo-N1H/Me

3.35

3.39

3.25/2.73

3.85/2.72

4.06

2.84

3.39

endo-N1H/Me

4.32

4.43

4.58/3.13

5.04/3.02

3.03

3.27

4.37

N2H/Me

5.57

3.22

5.53

3.21

3.24

3.24

DMSO-d6

acetone-d6

acetonitrile-d3

4.3.2.1 meso-exo-[Re(CO)3(N,N′,N′′-Me3dien)]PF6 (meso-exo-4). The isomerically pure
meso-exo-[Re(CO)3(N,N′,N′′-Me3dien)]PF6 salt in DMSO-d6 has one set of 1H NMR signals that
included one relatively upfield NH signal (integrating to 2H) at 5.15 ppm (typical chemical shift
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for secondary amine NH = ~7 ppm) and one methyl doublet (2.94 ppm). The spectrum remained
unchanged even after two days. As mentioned above, a mixture of the meso-exo and the chiral
isomer of [Re(CO)3(N,N′,N′′-Me3dien)]PF6 (ratio 1:1) was also isolated in the synthesis. The 1H
NMR spectrum (DMSO-d6) of this mixture reveals a relatively downfield (6.39 ppm) small NH
signal and a relatively upfield (5.15 ppm) large NH signal, which are respectively assigned to the
endo-NH of chiral-[Re(CO)3(N,N′,N′′-Me3dien)]PF6 (chiral-4) and to overlapping signals of the
exo-NH of chiral-4 and the two exo-NH’s of meso-exo-4.
Sodium hydroxide was added to a DMSO-d6 solution (5 mM, 600 µL) of the isolated
meso-exo-[Re(CO)3(N,N′,N′′-Me3dien)]PF6 complex in order to catalyze isomerization at N1 or
N3 of the meso-exo isomer (meso-exo-4) for conversion to other isomers. Upon addition of base
(DMSO-d6/0.04 M NaOH, 600 µL/10 µL, final [OH-] = 0.6 mM), a new set of signals, belonging
to a new isomer, appeared within minutes, and the NH signal of meso-exo-4 shifted slightly
downfield to 5.26 ppm. The intensities of the new signals continued to increase for ~2 h, and the
final ratio of the signals of the new isomer to those of the meso-exo isomer was 1:2 (the sample
was then monitored for 5 months and no further change was observed). The new set of signals
included one downfield (6.39 ppm) and one relatively upfield (5.13 ppm) NH signal (for a
secondary amine) and one relatively downfield (2.90 ppm) and one relatively upfield (2.66 ppm)
methyl doublet signal. In a 1H-1H COSY NMR experiment (Appendix C), the relatively
downfield NH signal gave a cross-peak to the relatively upfield methyl signal, while the
relatively upfield NH signal gave a cross-peak to the relatively downfield methyl signal. These
cross-peaks allowed the assignment of the new signals to the chiral isomer. By analogy to these
assignments for the [Re(CO)3(N,N′,N′′-Me3dien)]+ isomers, we can assign the unusually upfield

79

NH signal in the spectra of complexes 1 to 3 to the exo-NH and the relatively downfield NH
signal to the endo-NH.
Isomerization of a secondary amine group bound to a Re(CO)3 moiety at high pH was
also observed for [Re(CO)3(ENDAC)]-.8 The terminal amine substituents are a proton and a
dangling acetyl group (CH2CO2-). Both isomers were isolated as the neutral Re(CO)3(ENDACH)
complex. The NH signal of the endo isomer had a chemical shift at 5.84 ppm, whereas the exo
isomer had an NH signal at 5.34 ppm in DMSO-d6. Even though the difference in shift of the two
signals is not so large as the difference in shift of the signals of chiral-4, the signal assignment is
still consistent with our assignment that the exo-NH is the relatively upfield signal and the endoNH is the relatively downfield signal.
As described above, upon addition of base to a DMSO-d6 sample containing the pure
meso-exo isomer of [Re(CO)3(N,N′,N′′-Me3dien)]PF6 (meso-exo-4), the exo-NH signal of this
starting meso-exo-4 complex moved downfield, and isomerization at a terminal amine group
occurred. When only H2O was added to such a DMSO-d6 sample, the meso-exo-4 exo-NH signal
did not shift. The effect of base was also studied with a DMSO-d6 solution of the isolated noncrystalline mixture of [Re(CO)3(N,N′,N′′-Me3dien)]PF6 (5 mM, 600 µL, meso-exo-4 to chiral-4
isomer ratio 1:1). Upon addition of base (DMSO-d6/0.1 M NaOH, 600 µL/10 µL, final [OH-] =
1.7 mM) only the exo-NH signal of meso-exo-4 shifted downfield by ~0.5 ppm, whereas the NH
signals of the chiral-4 remained unchanged. In an essentially identical base addition experiment
with [Re(CO)3(dien)]PF6, no NH signal shift change was observed.
The downfield shift observed for the exo-NH signal of the meso-exo isomer of
[Re(CO)3(N,N′,N′′-Me3dien)]PF6 upon addition of NaOH might be related to the fact that the two
exo-NH groups of meso-exo-4 project in the same direction and are relatively fixed in position
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by the endo-Me groups. The chiral-4 isomer has one endo and one exo NH and the NH’s of
[Re(CO)3(dien)]PF6 may not be at a fixed position because chelate rings are conformationally
dynamic. These considerations lead us to suggest that the relatively selective shift effect for
meso-exo-4 could be the result of a hydroxo/water solvation cluster bridging the two NH’s. In
addition, the absence of such a cluster for the dien complex could be caused by the difference in
solvation of the primary amines vs. the secondary amines in meso-exo-4.
4.3.2.2 Interaction of NH Protons with Cl¯ Anion. Understanding the basis of the very
different NH shifts of the fac-[Re(CO)3L] complexes is a challenge. The shift difference we
observe could arise from different exposure of the NH group to solvent. To test this possibility
we added Cl¯ to DMSO-d6 solutions of representative complexes. This anion is known to form
H-bonds in non-aqueous solvents. If any H-bonding occurs between NH and Cl¯, we would
expect the NH signal to shift downfield.32,33
Indeed, when Cl¯ (1 to ~175 mM) was added to a solution of [Re(CO)3(dien)]+ (5 mM,
DMSO-d6), the upfield NH signal assigned to the exo-NH groups shifted downfield (Δδ ~ 1.2
ppm) and reached a plateau at ~100 mM of Cl¯, whereas the downfield NH signals assigned to
the endo-NH’s and the central N2H remained relatively unchanged. Figure 4.5 shows the change
in chemical shift (Δδ) vs. the amount of Cl¯ added. Even after the addition of more Cl¯, the
endo-NH and the central N2H signals do not change significantly. In a similar experiment with
[Re(CO)3(daes)]PF6 (6) (2.6 mM, DMSO-d6), upon Cl¯ addition the final Δδ observed was 0.9
ppm (at 100 mM) for the exo-NH signal giving a final shift of 5.13 ppm for the
[Re(CO)3(daes)]+, Cl¯ ion pair, a value relatively close to the 5.33 ppm observed for the exo-NH
signal [Re(CO)3(dien)]+,Cl¯ ion pair.
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Figure 4.5. Change in chemical shift (Δδ) of exo-NH, endo-NH and N2H signals of
[Re(CO)3(dien)]PF6 upon addition of Cl¯ in DMSO-d6.
Behavior similar to that of [Re(CO)3(dien)]PF6 was observed when Cl¯ (1 to ~175 mM)
was added to a solution of an isomeric mixture of meso-exo-4 and chiral-4 (5 mM, DMSO-d6).
The exo-NH signal of meso-exo-4 shifted downfield (Δδ between the final and initial chemical
shifts ~1.5 ppm) and the relatively upfield exo-NH signal of chiral-4 shifted downfield (Δδ ~ 1.1
ppm).

However, the relatively downfield endo-NH signal of chiral-4 shifted downfield

minimally (Δδ ∼ 0.25 ppm). Small changes were also observed in the CH signal of the ethylene
chains.
Assuming that the final ion pair has a 1:1 ratio, we calculated from the data used to plot
Figure 4.5 and figures in Appendix C equilibrium constants of 93 ± 5 M-1 for
[Re(CO)3(dien)]+,Cl¯; 96 ± 11 M-1 for [Re(CO)3(daes)]+,Cl¯; and 56 ± 8 and 239 ± 23 M-1 for
chiral- and meso-exo-[Re(CO)3(N,N′,N′′-Me3dien)]+,Cl¯ ion pairs, respectively. The significantly
higher binding constant for meso-exo-4, compared to those of 1 and chiral-[Re(CO)3(N,N′,N′′-
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Me3dien)]+ might be attributed to the fixed location of the exo-NH’s of meso-exo-4, as discussed
above.
In contrast to the above results, when Cl¯ was added to solutions of complexes that have
only one terminal NH2 group, the exo-NH did not appear to interact strongly with Cl¯.
Specifically, when as much as 80 mM Cl¯ was added to 5 mM DMSO-d6 solutions of
[Re(CO)3(N,N-Me2dien)]PF6 and of Re(CO)3(DNS-dien),10 no significant NH shift change was
observed. Obviously, it is necessary to have at least one NH in each terminal amine group for Hbonding with Cl¯ to occur. Only small changes in shift of the endo-NH, N2H and CH signals of
1, meso-exo-4, and chiral-4 were observed, and these are attributable to non-specific salt or ionic
strength effects. On the other hand, the downfield shift by at least 1 ppm of the exo-NH signals
of 1, meso-exo-4, and chiral-4, attributable to NH - - Cl¯ hydrogen bonding within the ion pair,
correlates roughly with the magnitude of the equilibrium constant. These findings indicate that
the Cl¯ indeed interacts with the two exo-NH’s in complexes 1, meso-exo-4, and 6, and are
consistent with the ion pair model for H-bonding between Cl¯ and the exo-NH’s proposed in
Figure 4.6. The distances of the Cl¯ ion to N1 and N2, 3.258 and 3.289 Å, respectively, are very
similar to the distances observed in the solid state for fac-[Pt(IV)(dien)Cl3]Cl,34 where the Cl¯
counter ion was H-bonded to the two terminal NH2 groups with Cl¯ to N distances of 3.252 and
3.245 Å.
The effects of Cl¯ addition were also examined for acetonitrile-d3 solutions of
[Re(CO)3(dien)]PF6 and a mixture of meso-exo and chiral [Re(CO)3(N,N′,N′′-Me3dien)]PF6.
However, a much lower concentration of Cl¯ (20 mM) was necessary to reach the final
downfield shifts. In this solvent, Δδ had a nearly linear dependence on Cl¯ concentration
(Appendix C); therefore, binding constants could not be calculated. The Δδ values for the exo-
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NH signals of 1, meso-exo-4, and chiral-4 (~ 2.7, 2.4, and 2.7 ppm, respectively) in acetonitriled3 were greater than in DMSO-d6 and also greater than for the central N2H signal of
[Re(CO)3(dien)]+ and the endo-NH signal of chiral-4 (Δδ ~ 1.3 and 1.4 ppm, respectively, in
acetonitrile-d3). The final "absolute" chemical shift values of these signals were similar in both
DMSO-d6 and acetonitrile-d3. This latter finding, combined with the observed larger Δδ values
and apparently much larger binding constants for acetonitrile-d3, can be explained by the weaker
hydrogen bonding of this solvent, an acetonitrile-d3 property which allows better competition for
the NH by Cl¯ and which leads to a lower initial chemical shift for the NH signals.

Figure 4.6. Space-filling model of 1a showing the orientation of the exo-NH’s and endo-NH’s
relative to the pocket formed by the ethylene chains of dien. Also shown (right) is the proposed
positioning of the Cl¯ ion for H-bonding between the exo-NH’s.

To understand these interactions better, we examined dien complexes with the ligand
coordinated in a meridional fashion. The 1H NMR spectrum of [Pt(dien)Cl]Cl (DMSO-d6, 5
mM) exhibits two sets of three NH signals each: an upfield set for [Pt(dien)Cl]+ and a downfield
set for [Pt(dien)(Me2SO-d6)]2+.29 Upon Cl¯ (~ 100 mM) addition to a such a solution, the
[Pt(dien)(Me2SO)]2+ NH signals shifted downfield (from 6.43 and 6.52 ppm to 6.78 and 6.86
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ppm, respectively, for the terminal NH2 groups and from 7.10 to 8.66 ppm (Δδ ~ 1.6 ppm) for
the central NH group). In contrast, for [Pt(dien)Cl]+, the two terminal NH2 signals (5.43 and 5.51
ppm) did not change, and only the central NH signal shifted (from 7.10 to 7.78 ppm, Δδ ~ 0.7
ppm). The X-ray structure of [Pt(dien)Cl]Cl (meridional coordination of dien), (unpublished
data) suggests that the central NH is somewhat shielded from the solvent by the two ethylene
chains (cf. figure in Appendix C). Consequently, the central NH is not readily available to form
H-bonds with DMSO-d6. Upon Cl¯ addition, we believe that the obstructed central NH forms Hbonds with the relatively small Cl¯ ion (vs. the bulkier DMSO-d6). In contrast, analysis of the Xray structure of fac-[Re(CO)3(dien)]+ suggests that the central NH will be relatively exposed to
the solvent (the two ethylene chains project away from the central NH, cf. figure in Appendix C).
Thus, the central NH is available for H-bonding with the solvent, disfavoring interaction with the
Cl¯ ion. The insignificant change in chemical shift of the terminal NH2 signals in [Pt(dien)Cl]+ is
attributed to the presence of the chloro ligand creating a localized negatively charged region
inhibiting Cl¯ ion interaction near the terminal NH2 groups. Also, in [Pt(dien)(Me2SO)]2+ the
bulky Me2SO ligand prevents strong interaction of the Cl¯ ion with the terminal NH2 groups.
Thus, contrary to what is observed for the fac-[Re(CO)3L] complexes, interaction of Cl¯ ion at
the central NH group of Pt(dien) complexes is more favorable than at the terminal amines.
From the locations of both the endo- and exo-NH protons of the terminal amine of the
different fac-[Re(CO)3L] structures, we believe that the exo-NH's are somewhat protected from
the solvent, whereas the endo-NH's seem to be more exposed to the solvent. Space-filling models
of the X-ray structures show that the exo-NH points slightly toward the pocket formed by the
ethylene chains of L (Figure 4.6). In contrast, the endo-NH, which points toward the carbonyl
ligands and away from any L bulk, appears to be more exposed to the solvent. The X-ray
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structure of [Pt(dien)Cl]Cl (unpublished data) indicates that the exo and endo NH protons should
have a similar exposure to solvent, explaining the much smaller difference in the chemical shift
of the two NH signals compared to the difference observed for fac-[Re(CO)3L] complexes.
4.4 Conclusions
The simple prototypical ligands studied here bind to the fac-Re(CO)3 core in tridentate
mode, giving cations of the fac-[Re(CO)3L]+ type. Most complexes reported here have the same
chirality in each chelate ring, a finding in accord with our observation that less severe steric
clashes between rings would occur when both rings have the same chirality. However, our results
are surprisingly in contrast in the light of literature surveys, which show that complexes of the
fac-M(dien) type with different chirality occur more often. An interesting finding was the
downfield shifting of the exo-NH’s of the meso-exo-[Re(CO)3(N,N′,N′′-Me3dien)]PF6 complex
upon addition of base. This effect might be caused by the formation of a hydroxo/water solvation
bridge between the two exo-NH’s, which probably are in a relatively fixed position in this mesoexo isomer. Addition of Cl¯ caused downfield shifting of the relatively upfield exo-NH’s of
[Re(CO)3(dien)]+ and two isomers of [Re(CO)3(N,N′,N′′-Me3dien)]+, suggesting that hydrogen
bonding occurs between the exo-NH’s and the Cl¯ ion. This finding indicates that the exo-NH’s
are protected from the solvent environment and therefore have relatively upfield chemical shifts
compared to the endo-NH’s. The interactions of the various ligand groups in tracer metal
complexes influence biodistribution and must be understood in order to improve methods of
targeting such tracers. NMR methods are among the best approaches for assessing interactions of
tracer complexes in solution. The types of analysis that we have presented can be viewed as
being in their infancies. Some of the unusual and as yet incompletely explained NMR shifts of
Re analogues of

99m

Tc tracers very probably reflect differences in solvation of the various parts
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of the bound ligands. We believe that more investigations of this type will be needed for rational
design of tracers.
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CHAPTER 5. CONCLUSIONS
In general the sulfonamide ligands proved to be excellent ligands for both the Pt(II) and
fac-Re(CO)3 metal centers. The DNSH-dienH ligand can act as a bidentate, tridentate, or
quadridentate ligand in Pt(II) complexes, and the tmbSO2-dien and tmbSO2-dipn ligands can act
as bidentate or tridentate in fac-[Re(CO)3L] complexes. In general high pH is necessary for the
sulfonamide group to deprotonate and bind to the metal center, whereas in low pHs only the
amine groups of the tridentate ligand bind.
We achieved the synthesis of a new Pt(II) complex, Pt(DNSH-dien)Cl, which increases
the reactivity toward 5′-GMP relative to that toward met. Therefore, such a complex might act as
a model for the development of a new class of Pt(II) drugs with lower reactivity toward Scontaining biomolecules and consequently less toxicity than cisplatin.
The sulfonamido group in the fac-[Re(CO)3L] (L = sulfonamide ligands) complexes can
act as a potential anchor for bioconjugation, while giving complexes with neutral net charge,
indicating that this class of tridentate ligands should be useful in the development of
radiopharmaceuticals with a 99mTc(CO)3 label.
The NMR investigation of fac-[Re(CO)3L] complexes with the simple NNN and NSN
prototypical ligands provided insight into the basis of the existence of one unusual NH signal in
several fac-[Re(CO)3L] complexes with terminal amino groups. We were able to assign the
relatively upfield NH signal to the exo-NH proton and we believe that this unusual upfield
chemical shift might be attributed to its limited exposure to the solvent environment.
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APPENDIX A. fac-[Re(CO)3L] COMPLEXES CONTAINING TRIDENTATE
MONOANIONIC LIGANDS (L¯) HAVING A TERMINAL AMIDO AND TWO AMINE
LIGATING GROUPS*
A.1 Introduction
Technetium-99m (99mTc) is the most widely used diagnostic radionuclide in nuclear
medicine.1-4 The [99mTc(V)O]3+ core has been used most predominantly, but recently the
development of the advantageous [99mTc(CO)3(H2O)3]+ precursor has opened new directions for
radiolabeling.5-7 Schibli et al. showed that agents with the fac-99mTc(I)(CO)3+ core bearing a
tridentate coordinated ligand are more robust and have better pharmacokinetic profiles than
agents bearing bidentate ligands.8 Frequently used chelating ligands contain N, O, or S donor
atoms in groups such as carboxyls,9 amines,10,11 nitrogen heterocycles,12 and thioethers.13,14 A
neutral metal-containing label is most useful in the development of small (~5 kDa) metal nuclide
radiopharmaceuticals for bioconjugation to hormones, small peptides, etc. because such neutral
labels are most likely to preserve the biological properties of the tagged species.15 Complexes
made from the non-radioactive fac-[Re(CO)3(H2O)3]+ analogue of fac-[99mTc(CO)3(H2O)3]+
generally provide the necessary background to define the chemistry of the

99m

Tc agents.13 A

neutral labeling unit can best be achieved by using monoanionic tridentate ligands. The most
common negative donor, the carboxyl group, does not allow bioconjugation, however. We
recently reported a series of fac-[Re(CO)3(NNN)] complexes of monoanionic tridentate ligands
with three nitrogen donors (NNN) containing the seldom-used sulfonamido group.16 In the
names of the NNN ligands (LH) used here (cf. caption of Figure 4.1), the H’s designate the
sulfonamide and amide NH proton that is absent in the facially coordinated deprotonated bound
*

Submitted to the Journal of Chemical Crystallography: Christoforou, A. M., Marzilli, P. A.,
Fronczek, F. R., Marzilli, L. G., "fac-Re(CO)3L Containing Tridentate Monoanionic Ligands
(L¯) Having a Termianl Amido Group and Two Amine Ligating Groups"
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L¯. The sulfonamido group offers diverse chemistry and allows bioconjugation through the
terminal ligating group. The amido group is very commonly used in bioconjugation chemistry
because of its significance in peptides. Although the amido group has been widely used as a
ligating group in M(V)O3+ radiopharmaceuticals,

17

very little use of this group has been made

for fac-99mTc(I)(CO)3 agents, especially as a terminal ligating group.18 Herein, we describe the
fac-[Re(CO)3L] complexes formed by fac-[Re(CO)3(H2O)3]+ with tmbCO-N,N-Me2dienH and
tmbCO-dienH, containing the monoanionic deprotonated amido ligand bound in a tridentate
fashion. Because all compounds described herein have a facial arrangement of the three
carbonyls, hereafter the fac designation will be used only in referring to general types of
compounds and will be omitted when referring to specific compounds.

Figure A.1. Ligands used in this study: N-[2-(2-dimethylaminoethylamino)-ethyl]-2,4,6trimethylbenzamide (tmbCO-N,N-Me2dienH); and N-[2-(2-aminoethylamino)-ethyl]-2,4,6trimethylbenzamide (tmbCO-dienH) and ligands referred to in the text: N-[2-(2dimethylaminoethylamino)-ethyl]-2,4,6-trimethylbenzenesulfonamide (tmbSO2-N,N-Me2dienH)
and N-[2-(2-aminoethylamino)-ethyl]-2,4,6-trimethylbenzenesulfonamide (tmbSO2-dienH). The
H’s in the ligand names designate a sulfonamide/amide proton lost upon Re binding.
In fac-[99mTc(CO)3L] agents, the bioconjugation emanates from an atom of one chelate
ring of the tridentate ligand. Because chelate ring atoms act as a fulcrum, the configuration of
asymmetric centers, the shape, and the conformation of the rings can have a large effect on the
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overall shape of the agent, and hence on its biological activity. Therefore, it is clearly important
to understand how the ligand pucker depends on the various components that can influence it
(donor atoms, chains linking these atoms, exocyclic substituents, etc.).
Although chelate ring pucker and factors affecting pucker have not been thoroughly
examined for radiopharmaceuticals, extensive structural information exists for a large number of
complexes with other metals containing chelate rings with an ethylene group bridge between
ligating atoms. Many of these structures have been analyzed by using principal component
analysis (pca) and other methods.19-26 When diethylenetriamine-type ligands bind to a metal
center in a tridentate fashion, the two five-membered chelate rings can have either δ or λ
chirality (Chart 1), leading to four possible combinations of chelate ring chirality: δλ, λδ, λλ and
δδ.
Chart A.1

Pca studies on X-ray structures from the Cambridge Structural Database (CSD) of
M(dien) structures19-21 showed that the δλ and λδ conformation combinations were found much
more frequently than those with the λλ and δδ pucker chirality.
A.2 Experimental Section
A.2.1 Starting Materials. N,N-dimethyldiethylenetriamine (N,N-Me2dien) from Ames
Laboratories, 2,4,6-trimethylbenzoyl chloride (tmbCOCl) from Alfa Aesar, diethylenetramine
(dien) and Re2(CO)10 from Aldrich were all used as received. The [Re(CO)3(H2O)3]OTf13 (OTf =
trifluoromethanesulfonate) precursor was prepared by known methods.
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A.2.2 NMR Spectroscopy. 1H NMR spectra were recorded on either a 300 MHz or 400
MHz spectrometer. Peak positions are relative to TMS or solvent residual peak, with TMS as
reference. All NMR data were processed with XWINNMR and Mestre-C software.
A.2.3 X-ray Data Collection and Structure Determination. All single crystals suitable
for X-ray crystallography were obtained by slow evaporation from acetone or methanol. Single
crystals were placed in a cooled nitrogen gas stream at 90 K on a Nonius Kappa CCD
diffractometer fitted with an Oxford Cryostream cooler with graphite-monochromated Mo Kα
(0.71073 Å) radiation. Data reduction included absorption corrections by the multi-scan method,
with HKL SCALEPACK.27 All X-ray structures were solved by direct methods and difference
Fourier techniques and refined by full-matrix least squares techniques using SHELXL97.28 All
non-hydrogen atoms were refined anisotropically. All hydrogen atoms were visible in difference
maps, but were placed in idealized positions. A torsional parameter was refined for each methyl
group.
A.2.4 Synthesis of fac-[Re(CO)3L]. The crude ligands, LH, were synthesized by a slight
modification of Krapcho’s method.29 A solution of the acyl chloride (tmbCOCl) (~5 mmol, 100
mL of dioxane) was added dropwise over the course of about 2 h to a solution of the amine (~50
mmol, 100 mL of dioxane). The reaction mixture was stirred at RT for 10 h. The dioxane was
completely removed under vacuum, and water (50 mL) was added. The product was extracted
into CH2Cl2 (2 × 100 mL), and the solvent was removed under rotary evaporation. The oil thus
obtained was used to synthesize the fac-[Re(CO)3L] complexes as follows: an aqueous solution
of [Re(CO)3(H2O)3]+ (10 mL, 0.1 mmol) was treated with a methanol (5 mL) solution of the
ligand (0.1 mmol). The pH was adjusted to ~5 and the reaction mixture was heated at reflux for
10 h, then allowed to cool at RT, and the pH was increased to ~ 7. The resulting white solid that
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precipitated was collected on a filter, washed with water, and dried under vacuum. This
procedure succeeded with LH having an amide group, but the procedure was less reliable than
for the analogues with the sulfonamide group.
A.2.4.1 [Re(CO)3(tmbCO-N,N-Me2dien)] (1). The general method, with 1 g of
tmbSO2Cl and 6 mL of N,N-Me2dien, afforded the crude tmbCO-N,N-Me2dienH ligand (650 mg,
45% yield). 1H NMR (ppm) in CDCl3: 6.82 (s, 2H), 6.50 (b, 1H, NH), 3.52 (t, 2H, CH2), 2.84 (t,
2H, CH2), 2.68 (t,2H, CH2), 2.35 (t, 2H, CH2), 2.29 (s, 3H, CH3), 2.26 (s, 6H, CH3), 2.28 (s, 3H,
CH3), 2.15 (s, 6H, NCH3). Treatment of [Re(CO)3(H2O)3]+ (0.1 mmol) with tmbCO-N,NMe2dienH (27 mg) as described above afforded [Re(CO)3(tmbCO-N,N-Me2dien)] as a white
powder, (12 mg, 22% yield). Crystals obtained by slow evaporation from acetone were
characterized by single-crystal X-ray crystallography. 1H NMR (ppm) spectrum in acetone-d6:
6.78 (s, 1H), 6.75 (s, 1H), 6.14 (b, 1H, N2H), 3.47 (m, 1H, CH2), 3.25 (m, 3H, CH2), 3.12 (m,
2H, CH2), 3.12 (s, 3H, NCH3), 2.97 (s, 3H, NCH3), 2.87 (m, 2H, CH2), 2.21 (s, 3H, CH3), 2.18
(s, 3H, CH3), 2.13 (s, 3H, CH3).
A.2.4.2 [Re(CO)3(tmbCO-dien)] (2). The general method, with tmbCOCl (1 g) and dien
(5 mL), yielded the crude tmbCO-dienH ligand (650 mg, 45% yield). 1H NMR (ppm) in CDCl3:
6.80 (s, 2H), 6.27 (b, 1H, NH), 3.53 (t, 2H, CH2), 2.85 (t, 2H, CH2), 2.77 (t,2H, CH2), 2.67 (t,
2H, CH2), 2.28 (s, 3H, CH3), 2.26 (s, 6H, CH3). Treatment of [Re(CO)3(H2O)3]+ (0.1 mmol) with
tmbCO-NMe2dienH (25 mg) as described above afforded [Re(CO)3(tmbCO-NMe2dien)] as a
white powder (15 mg, 29% yield). Crystals obtained by slow evaporation from acetone were
characterized by single-crystal X-ray crystallography. 1H NMR (ppm) spectrum in acetone-d6:
6.79 (s, 1H), 6.75 (s, 1H), 6.16 (b, 1H, N2H), 4.86 (b, 1H, N1H), 4.52 (b, 1H, N1H), 3.31 (m,

95

1H, CH2), 3.16 (m, 1H, CH2), 3.08-2.94 (m, 5H, CH2), 2.67 (m, 1H, CH2), 2.20 (s, 3H, CH3),
2.18 (s, 6H, CH3).
A.3 Results and Discussion
A.3.1 X-Ray Characterization. Both complexes reported here (Figure A.2) have a
distorted octahedral structure, with the three carbonyl ligands coordinated facially. The
remaining coordination sites are occupied by two sp3 N amines and one sp2 N from an amido
group. Typically, the Re−C(3) bonds, involving the CO group trans to the amido group, are not
different from those of the other Re−CO bonds or the respective Re−C(3) bonds of the relevant
sulfonamido complexes.16 Crystal data and structural refinement details are summarized in Table
A.1 for 1 and 2. Although we found that the aromatic rings facilitated our efforts to obtain
crystals, these rings generally were not stacked.

Figure A.2. Perspective drawings of the S configuration of [Re(CO)3(tmbCO-N,N-Me2dien)] (1)
and [Re(CO)3(tmbCO-dien)] (2). Thermal ellipsoids are drawn with 50% probability.
A.3.2 Bond Lengths and Bite Angles. The average Re−N bond length of ~2.2 Å (Table
A.2) found in the amido complexes is consistent with distances found in relevant fac[Re(CO)3L] complexes.11,14,16 The Re−N1 bond (N1Me2 group) in [Re(CO)3(tmbCO-N,N96

Me2dien)] (1) is longer than the other Re−N bonds of 1 and 2. This lengthening is attributed to
the bulkiness of the two methyl groups on N1 (for 1) compared to the smaller H group in 2.
Similar results, were observed for the respective bonds of fac-[Re(CO)3L] (L = tmb-sulfonamido
ligands) complexes.
Table A.1. Crystal Data and Structural Refinement for [Re(CO)3(tmbCO-N,N-Me2dien)] (1), and
[Re(CO)3(tmbCO-dien)] (2)
fac-[Re(CO)3L] complex
1
empirical formula
fw
crystal system
space group

2

C19H26N3O4Re

C17H22N3O4Re•H2O

546.63

536.59

monoclinic

monoclinic

P21/c

C2/c

a (Å)

19.5793 (15)

36.861 (7)

b (Å)

7.4239 (5)

7.3990 (10)

c (Å)

14.8071 (10)

14.933 (3)

β (°)

104.425 (5)

102.145 (8)

V (Å3)

2084.4 (3)

3981.6 (12)

T (K)

90

90

Z

4

8

ρcalc (mg/m3)

1.742

1.790

μ (mm-1)

5.857

6.135

0.387-0.474

0.373-0.837

2θmax (°)

73.8

65.2

R indicesa

0.027

0.032

wR2 = [I> 2σ(I)]b

0.060

0.077

data/param

9895/253

7003/245

resid. dens. (Å-3)

1.39, -2.14

1.78, -1.88

transm. coeff.
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Table A.2. Selected Bond and Atom Distances (Å) and Angles (deg) for [Re(CO)3(tmbCO-N,NMe2dien)] (1), and [Re(CO)3(tmbCO-dien)] (2)
fac-[Re(CO)3L] complex
1

2

bond distances
Re–N1

2.2738 (19)

2.216 (3)

Re–N2

2.2087 (19)

2.207 (3)

Re–N3

2.1744 (17)

2.185 (3)

bond angles
N1–Re–N2

79.37 (7)

77.87 (10)

N2–Re–N3

76.10 (7)

74.26 (10)

N1–Re–N3

85.81 (7)

90.16 (10)

N2–Re–C2

172.33 (9)

170.10 (13)

non-bonded distances
N1 to N2

2.863

2.779

N2 to N3

2.702

2.651

C4 to C7

3.308

4.169

C4H to C7H

2.299

4.621

C5 to C6

2.510

2.468

C5H to C6H

2.283

2.586

It is known that the sp2 N donors can form shorter Re−N bonds than the sp3 N donors.12,30
The Re−N3 sp2 bond of the amido group in both 1 and 2 is statistically shorter than the
respective Re−N1 and Re−N2 bonds (which are Re−sp3N bonds). The shorter Re−N3 sp2 bond
compared to the Re−N sp3 bonds was also observed in similar fac-[Re(CO)3L] (L = tmbsulfonamido ligands) complexes.16 The effect of the hybridized sp2 N3 should also be seen in the
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N3−C7 bond. Indeed, the N3−C7 bond is numerically (but not significantly) shorter than the
other sp3 N−C bonds (N1−C4, N2−C5, and N2−C6). Typical Re−sp2 N bond lengths range from
2.14 to 2.18 Å, as measured in a several Re structures containing Re−N bonds (aromatic sp2 N,
e.g., in pyridyl ligands), whereas a typical Re−sp3 N bond length is ~2.2 Å.12-14 The sp2
hybridized N3 should affect the C−N3−C7, C−N3−Re, and C7−N3−Re angles. However, the
differences between molecules, while generally consistent with expectations for Re−sp2 N vs.
Re−sp3 N centers, are small and thus are masked by steric and solid state effects. The N−Re−N
bite angles in the amido complexes are between 74.2 and 79.3°. The N2−Re−N3 bite angle (ring
containing the amido group) is smaller (~75°) than the N1−Re−N2 bite angle (~78°), as found
for the related angles in fac-[Re(CO)3L] (L = tmb-sulfonamido ligands) complexes.16 The N1 to
N2 and N2 to N3 non-bonded distances within five-membered chelate rings in 1 and 2 have a
narrow range of values (Table A.2) and are similar to those of relevant fac-[Re(CO)3L]
complexes,16 as well as those of complexes with higher valent metal centers.31
A.3.3 Chelate Ring Chirality. As mentioned in the Introduction, chelate ring shape and
conformation affect the overall shape of the bioconjugated agent. In accordance with other
relevant compounds,20,21 and our findings for fac-[Re(CO)3L] sulfonamido complexes,16 1 has
different chirality in each ring pucker; λδ for the S configuration at Re (The Re configuration is
S for structures shown in Figure A.2).16 In contrast, both chelate rings have the same chirality in
complex 2 (both δ for the S configuration), a finding we attribute to two strong intermolecular
hydrogen bonds from the NH2 to two waters of crystallization (N…O 2.924(4) at x,y,z and
2.941(4) Å at 1-x, 1-y, 1-z). The fact that complex 2 has the same chirality in both rings is an
unusual but not unprecedented finding.16,19-21 The non-bonded distances between the chelate
rings agree with our previous study16 finding that C5 to C6 (Table A.2) and C5H to C6H
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distances are not very different whether the pucker chirality of the two chelate rings is the same
or different, whereas the C4 to C7 and C4H to C7H distances (cf. Figure A.2 for the atom
numbering) are larger than when the chirality is different.
We compared the position of the pendant group and the shape and chirality of the ring pucker
of complex 1 with its relevant sulfonamido complex.16 An overlay of the structure of complex 1
and the [Re(CO)3(tmbSO2-N,N-Me2dien)] complex (Figure A.3) illustrates that even though the
dien backbone of the ligand has a very good fit, the location of the pendant tmb group is
significantly different. These comparisons indicate that the change from an amido to a
sulfonamido ligating group does not affect the backbone structure, but the change in the nature of
the linkage of the tmb group to the coordinated nitrogen influences the position of the pendant
group.

Figure A.3. Overlay of the [Re(CO)3(tmbCO-N,N-Me2dien)] (red) and [Re(CO)3(tmbSO2-N,NMe2dien)] (blue) complexes (RMS = 0.026 Å from overlaying the Re, N1, N2, and N3 atoms).

A.3.4 Trimethylbenzyl Group Rotation. In the X-ray structures of 1 and 2 (Figure A.2),
the 3 and 5 protons and the 2 and 6 methyl groups of the tmbSO2 group are not equivalent.
Indeed, in the 1H NMR spectra of complexes 1 and 2, the signals of the magnetically
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inequivalent two aromatic protons and two methyl groups of the tmbCO group have similar
shifts (see Experimental Section) but are fully resolved. The signals do not merge when the
spectrum in acetone-d6 is recorded at 40 °C. In contrast, for fac-[Re(CO)3L] complexes with a
sulfonamido group instead of an amido group, these signals are combined for the aromatic and
for the methyl protons, indicating fast rotation on the NMR time scale.16

Figure A.4. Two views illustrating the possible steric clashes leading to restricted rotation
around the C (amido group)−C (tmb group) bond for 2.

In the X-ray structures of 1 and 2, the amido N3−C−O group is planar. Therefore, it can
adopt only two orientations with the oxygen facing away or towards the coordination face; in
both orientations serious clashes are observed when the tmb group is rotated around the
C−C(tmb) bond (with the help of modeling software). The conformer with the oxygen facing
towards the coordination face seems to be unfavorable because the tmb group is placed very
close to the carbonyl group and rotation of the tmb group would overlap with the carbonyl group.
In the second conformer (which is observed in the X-ray structures of 1 and 2) clashes of the
methyl group (of tmb) with the ethylene chain of dien appear to hinder rotation around the
C(amido)−C(tmb) bond. Similar clashes were observed also in the relevant fac-[Re(CO)3L] (L =
tmb-sulfonamido complexes) compexes16 during rotation the around the C(sulfonamido)−C(tmb)
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bond. The sulfonamido group S atom is part of longer bonds (N−S and S−C) bonds and a more
acute N3−S−C angle compared to the respective bonds (N3−C ~1.32 Å and C−C ~1.51 Å) and
angle (N3−C−C ~120°) of the amido group in the [Re(CO)3(tmbCO-dien)] and [Re(CO)3(N,NMe2tmbCO-dien)] complexes. The equivalence of the tmb signals of the sulfonamido complexes
despite the inequivalence in the X-ray structure16 was attributed to the relatively faster rotation of
the tmb group about the S(sulfonamido)−C(tmb) bond of the sulfonamido group compared to the
C(amido)−C(tmb) bond of the amido group,32 and that synchronous rotations about the longer
N−S and S−C bonds can explain the relatively free rotation of the tmb group for sulfonamido
complexes.16 We believe that for the fac-[Re(CO)3L] amido complexes (1 and 2) the
combination of the presence of only one favorable conformer, the short bonds and slow rotation
of the amido group result in hindered rotation around the C(amido)−C (tmb) bond, from clashes
of the methyl group (of tmb) with the ethylene chain (Figure A.4).
A.3.5 NMR Characterization of [Re(CO)3L] (L¯ = tmbCO-N,N-Me2dien¯ and
tmbCO-dien¯). The fac-[Re(CO)3L] complexes were characterized by NMR spectroscopy in
DMSO-d6, as well as in acetone-d6 (Table A.3). The [Re(CO)3(tmbCO-dien)] (2) complex has a
terminal NH2 group with one NH exo and one NH endo to the tricarbonyl face, which give rise
to a relatively upfield exo-NH signal (3.94 ppm) and a relatively downfield endo-NH signal (4.99
ppm) in DMSO-d6. These shifts (Table A.3) are roughly comparable to those for the terminal
NH2 group of relevant fac-[Re(CO)3L] (L¯ = tmb-sulfonamido ligands) complexes (3.30 to 3.54
ppm for upfield NH signal and 5.21 to 5.26 ppm for downfield NH signal).16 The exo-NH signal
of [Re(CO)3(tmbSO2-dien)] is ~0.5 ppm more upfield compared to that of 2, a difference that
might be attributed to the different distance of the exo-NH protons to the nearest oxygens of the
sulfonamido/amido group. The distance of the exo-NH of 2 to the oxygen of the CO group is 3.5
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Å, whereas the respective distance for the [Re(CO)3(tmbSO2-dien)] complex is 2.8 Å. The
explanation for the relatively upfield shift of the exo-NH signal is unclear, but such a signal
appears to be a general finding for fac-[Re(CO)3L] complexes with an exo-NH group. One
possibility is that steric effects obstruct formation of H-bonds with the solvent and therefore the
downfield shift effect of NH H-bonding to solvent is decreased.

Table A.3. Selected Chemical Shifts (ppm) of [Re(CO)3(tmbCO-N,N-Me2dien)] (1), and
[Re(CO)3(tmbCO-dien)] (2)
1

2

exo-N1H/Me

2.79

3.94

endo-N1H/Me

3.02

4.99

N2H

6.72

6.69

exo-N1H/Me

2.97

4.53

endo-N1H/Me

3.12

4.86

N2H

6.14

6.17

DMSO-d6

acetone-d6

A.4 Conclusions
In our studies we find that the fac-[Re(CO)3L] amido complexes are much more difficult
to synthesize, compared to the related sulfonamido complexes, consistent with the scarcity of
related amido complexes in the literature. An inner coordination sphere with a neutral charge is
achieved upon binding of the tridentate monoanionic amido ligands in the fac-[Re(CO)3(NNN)]
complexes studied here. The dangling tmb group connected through the amido bond experiences
hindered rotation on the NMR time scale, due to the rigidity of the amido group (compared to the
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more flexible sulfonamido group). Complex 1 has different chirality in each chelate ring, as
commonly found in the literature, whereas complex 2 has same chirality in each chelate ring.
The pendant tmb group has very different positions in [Re(CO)3(tmbCO-N,N-Me2dien)] and
[Re(CO)3(tmbSO2-N,N-Me2dien)]. Therefore, the different linker components (CO and SO2) lead
to different overall shapes.
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APPENDIX B. SUPPLEMENTARY MATERIAL FOR CHAPTER 3
B.1 Synthesis and Crystal Data and Structural Refinement for Re(CO)3(DNS-dien)1
B.1.1

Synthesis

of

Re(CO)3(DNS-dien)

(4).

Treatment

of

0.1

mmol

of

[Re(CO)3(H2O)3]+ with 33.2 mg of DNS-dienH2 as described for Re(CO)3L afforded
Re(CO)3(DNS-dien) as a white powder (35 mg, 58% yield). Crystals obtained by slow
evaporation from methanol were characterized by single-crystal X-ray crystallography. 1H NMR
spectrum (acetone-d6) (ppm): 8.66 (d, 1H), 8.40 (d, 1H), 8.12 (d, 1H), 7.49 (q, 2H), 7.20 (d, 1H),
6.23 (b, 1H, N1H), 4.77 (b, 1H, N1H), 4.09 (b, 1H, N1H), 3.67 (m, 1H, CH2), 3.32-2.94 (m, 5H,
CH2), 2.92 (m, 1H, CH2), 2.85 (s, 6H, CH3).

Figure B.1. Perspective drawings of the S configuration of Re(CO)3(DNS-dien) (4).1 Thermal
ellipsoids are drawn with 50% probability.
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Figure B.2. Orientation of the SO2 group in complexes 1-4.
Table B.1. Crystal Data and Structural Refinement for Re(CO)3(DNSH-dien) (4)
Re(CO)3(DNSH-dien)
empirical
formula
fw
crystal system
space group

C19H23N4O5ReS

γ (°)

90.0

605.67

V (Å3)

2164.8 (8)

monoclinic

T (K)

110

P21/c

unit cell
dimensions
a (Å)

Re(CO)3(DNSH-dien)

12.527 (3)

Z

4

ρcalc (g/cm3)

1.858

abs coeff (mm-1)

5.748

b (Å)

13.934 (3)

2θmax (°)

61

c (Å)

12.603 (2)

R indicesa

0.036

α (°)

90.0

wR2 = [I> 2σ(I)]b

0.082

β (°)

100.249 (9)

a

data/param

R = (∑||Fο| - |Fc||)/∑|Fο|; bwR2 = [∑[w(Fο2 - Fc2)2]/∑[w(Fο2)2]]1/2
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6591/273

B.2 Comparison of Metric Information and Structural Features of Complexes 1-5
B.2.1 Distances of the ethylene chain carbons to the N−Re−N plane. The distances
between the carbons of the ethylene chains to the N−Re−N plane are listed in Table 3. For
complexes 1-4 in the sulfonamido-containing ring both C6 and C7 are below (away from the
triangular face of L¯) the N2−Re−N3 plane (Figure 4). In contrast, in the terminal amine ring C4
is above and C5 is below the N1−Re−N2 plane for complexes 1-3. In 4, C5 is also below the
plane but C4 is almost in the N1−Re−N2 plane (Table S2, Figure 4)
Table B.2. Distances of Ethylene Chain Carbons to the N–Re–N Plane (Sign Denotes if the C is
Above (Positive) and Toward the Ligand Coordinated Face or Below (Negative) and Away From
the Ligand Trigonal Face)
Re(CO)3L complex
1

2

3

4

C4 to N1–Re–N2

0.526/0.546

0.462

0.375

-0.026

C5 to N1–Re–N2

-0.104/-0.074

-0.145

-0.251

-0.652

C6 to N2–Re–N3

-0.750/-0.771

-0.697

-0.683

-0.294

C7 to N2–Re–N3

-0.249/-0.235

-0.148

-0.125

-0.836

Table B.3. Selected Torsion Angles (deg) for complexes 2-5 Used to Assign the NH2 1H NMR
Signals
Re(CO)3L complex
2

3

4

5

H1B–N1–C4–H4A

41.5

39.0

25.9

56.2

H1B–N1–C4–H4B

77.5

80.2

92.7

173.9

H1A–N1–C4–H4A

159.8

157.0

143.1

58.1

H1A–N1–C4–H4B

40.6

37.69

24.5

59.6
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Figure B.3. Drawing of Re(CO)3L, showing the torsion angle between N1H and C4H.

B.3 IR Spectroscopy.
The IR spectra of acetone solutions of complexes 1-5 exhibit three bands attributed to CO
stretching of the fac-Re(CO)3 moiety (Table S4); a sharp, strong band in the 2010-2027 cm-1
region and two broad bands in the 1860-1920-cm-1 region. These values are in a similar range of
those of relevant Re(CO)3 complexes containing amine chelate ligands3 as well those of the
[Re(CO)3(NH3)3]+ complex.4
Table B.4. CO-stretching Absorptions (cm-1)in the IR Spectra of Acetone Solutions of 1-5
Re(CO)3L complex
1

2

3

4

5

2015

2027

2019

2010

2010

1907

1920

1906

1888

1889

1877

1884

1883

1875

1860
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APPENDIX C. SUPPLEMENTARY MATERIAL FOR CHAPTER 4

Figure C.1. Change in chemical shift (Δδ) of exo-NH, endo-NH and N2H signals of
[Re(CO)3(dien)]PF6 upon addition of Cl¯ in acetonitrile-d3.

Figure C.2. Change in chemical shift (Δδ) of exo-NH signal of meso-exo-4 and exo-NH and
endo-NH signals of chiral-4 upon addition of Cl¯ in acetontrile-d3.
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Figure C.3. Change in chemical shift (Δδ) of exo-NH and endo-NH signals of
[Re(CO)3(daes)]PF6 upon addition of Cl¯ in DMSO-d6.

Figure C.4. Change in chemical shift (Δδ) of exo-NH signal of meso-exo-4 and exo-NH and
endo-NH signals of chiral-4 upon addition of Cl¯ in DMSO-d6.
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Figure C.5. Overlay illustration of complexes 6 (red) and 2 (blue) (RMS value = 0.125 from
overlaying the Re, N1, N2/S, and N2/N3 atoms). The N2-CH3 group of 2 is omitted for clarity.

Figure C.6. Orientation of central NH in [Pt(dien)Cl]Cl (left) and Re(CO)3(dien)]PF6 (right).
Counter ions are omitted for clarity.
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Figure C.7. 1H-1H COSY NMR spectrum of meso-exo-4 and chiral-4 (mixture obtained upon
isomerization with base) in DMSO-d6/0.04 M NaOH, 600 µL/10 µL.
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APPENDIX D. CRYSTALLOGRAPHC AND SPECTROSCOPIC DATA FOR
MISCELLANIOUS PLATINUM(II)-SULFONAMIDO COMPLEXES
Two types of ligands based on 2-aminopyridine (2-amp), diethylenetriamine (dien) or
ethylenediamine (en) with a 2,4,6-trimethylbenzoyl (tmbSO2) or methyl (CH3) group through a
sulfonamide group were used in this study. Treatment of cis-Pt(Me2SO)2Cl2 with the
sulfonamide ligands gave the neutral complexes Pt(2-ampSO2CH3)(Me2SO)Cl, Pt(2ampSO2tmb)(Me2SO)Cl, Pt(tmbSO2-en)(Me2SO)Cl, and Pt(tmbSO2-N,N-Me2dien)Cl. X-ray
crystallographic and NMR analyses confirm that in both the solid and solution states the ligands
based on 2-amp or en are bound to Pt(II) in a bidentate fashion with the sulfonamido group
being deprotonated. The coordination sphere is completed with a Cl ligand (trans to the
sulfonamido N) and a Me2SO ligand (trans to the pyridine N). The tmbSO2-N,N-Me2dienH
ligand is bound in tridentate fashion with the sulfonamido group being deprotonated.
D.1 Experimental Section
D.1.1

Starting

Materials.

2-aminomethylpyridine,

methanesulfonyl

chloride

(CH3SO2Cl) and 2-mesitylenesulfonyl chloride (tmbSO2Cl) from Aldrich were all used as
received. cis-Pt(Me2SO)2Cl2, tmbSO2-N,N-Me2dien and tmbSO2-en were synthesized as
described elsewhere.1,2
D.1.2 NMR Spectroscopy. 1H NMR spectra were recorded on either a 300 MHz or 400
MHz spectrometer. Peak positions are relative to TMS or solvent residual peak, with TMS as
reference. All NMR data were processed with XWINNMR and Mestre-C software.
D.1.3 X-ray Data Collection and Structure Determination. All single crystals suitable
for X-ray crystallography were obtained by slow evaporation from acetone or methanol. Single
crystals were placed in a cooled nitrogen gas stream at ~100 K on a Nonius Kappa CCD
diffractometer fitted with an Oxford Cryostream cooler with graphite-monochromated Mo Kα
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(0.71073 Å) radiation. Data reduction included absorption corrections by the multi-scan method,
with HKL SCALEPACK.3 All X-ray structures were determined by direct methods and
difference Fourier techniques and refined by full-matrix least squares techniques, by using
SHELXL97.4 All non-hydrogen atoms were refined anisotropically. All hydrogen atoms were
visible in difference maps, but were placed in idealized positions. A torsional parameter was
refined for each methyl group. Mercury Software was used for measuring torsion angles.
D.2 Pt(II) Complexes of 2-Aminopyridine-Sulfonamide Ligands.
D.2.1 Synthesis of 2-ampSO2R (R = CH3 or tmb)
A solution of the sulfonyl chloride (tmbSO2Cl or CH3SO2Cl) (~5 mmol, 100 mL of
dioxane) was added dropwise over the course of about 0.5 h to a solution of 2-amp (~10 mmol,
100 mL of dioxane). The reaction mixture was stirred at RT overnight. A white solid was present
in the reaction mixture at the end of the reaction. The dioxane was completely removed under
vacuum, and water (50 mL) was added. The product was extracted into CH2Cl2 (2 × 100 mL),
and the solvent was removed under rotary evaporation. The oil thus obtained was used to
synthesize the Pt(2-ampSO2R)(Me2SO)Cl complexes as follows.
D.2.1.1 Synthesis of 2-ampSO2CH3 (1). The general method, with CH3COCl (0.56 g)
and 2-amp (1.08 g), yielded the 2-ampSO2CH3 ligand (1.18 g, 65% yield). Crystals obtained
from CDCl3 were characterized by single-crystal X-ray crystallography. 1H NMR (ppm) in
CDCl3: 8.56 (d, 1H), 7.73 (t, 1H), 7.36 (t, 1H), 7.26 (d, 1H), 6.13 (b, 1H, NH), 4.47 (d, 2H, CH2),
2.91 (s, 3H, CH3).
D.2.1.2 Synthesis of 2-ampSO2tmb (2). The general method, with tmbCOCl (1.02 g)
and 2-amp (1.08 g), yielded the 2-ampSO2CH3 ligand (1.68 mg, 58 % yield). Crystals obtained
from slow evaporation of a CH2Cl2 solution were characterized by single-crystal X-ray
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crystallography 1H NMR (ppm) in CDCl3: 8.47 (d, 1H), 7.56 (t, 1H), 7.15 (m, 2H), 6.89 (s, 2H,
tmb), 6.00 (b, 1H, NH), 4.16 (d, 2H, CH2), 2.67 (s, 6H, CH3), 2.26 (s, 3H, CH3).
D.2.2 Synthesis of Pt(2-ampSO2R)(Me2SO)Cl (R = CH3 or tmb)
A methanol solution (20 mL) of cis-Pt(Me2SO)2Cl2 (0.5 mmol) and 2-ampSO2R (R =
CH3 or tmb) (0.5 mmol) in the presence of triethylamine (500 µL) was heated at 60 °C for 2 h.
The reaction mixture was allowed to stir at RT overnight. The yellow solid that precipitated was
collected, washed with diethyl ether and dried in vacuo.
D.2.2.1 Synthesis of Pt(2-ampSO2CH3)(Me2SO)Cl (3). Treatment of cis-Pt(Me2SO)2Cl2
(0.211 g) with 2-ampSO2CH3 (146 mg) afforded Pt(2-ampSO2CH3)(Me2SO)Cl (158 mg, 52 %
yield) as a yellow solid. Crystals obtained from slow evaporation of the reaction filtrate were
characterized by single-crystal X-ray crystallography. 1H NMR (ppm) in DMSO-d6: 8.92 (d,
1H), 8.15 (t, 1H), 7.80 (d, 1H), 7.59 (t, 1H), 4.56 (d, 2H, CH2), 2.59 (s, 3H, CH3).
D.2.2.2 Synthesis of Pt(2-ampSO2tmb)(Me2SO)Cl (4). Treatment of cis-Pt(Me2SO)2Cl2
(0.211 g) with 2-ampSO2CH3 (94 mg) afforded Pt(2-ampSO2CH3)(Me2SO)Cl (114 mg, 46 %
yield) as a yellow solid. Crystals obtained from slow evaporation of the reaction filtrate were
characterized by single-crystal X-ray crystallography. 1H NMR (ppm) in DMSO-d6: 8.61 (d,
1H), 7.91 (t, 1H), 7.58 (d, 1H), 7.36 (t, 1H), 6.73 (s, 2H, tmb), 4.36 (d, 2H, CH2), 2.73 (s, 6H,
tmb-CH3), 2.08 (s, 3H, tmb-CH3).
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Figure D.1. Perspective drawing of 2-ampSO2CH3 (1). Thermal ellipsoids are drawn with 50%
probability.

Figure D.2. Perspective drawing of 2-ampSO2CH3 (2). Hydrogen bonds observed in solid state
are depicted. Thermal ellipsoids are drawn with 50% probability.
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Figure D.3. Perspective drawings of Pt(2-ampSO2CH3)(Me2SO)Cl (3) and Pt(2ampSO2tmb)(Me2SO)Cl (4). Thermal ellipsoids are drawn with 50% probability.
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Table D.1. Crystal Data and Structural Refinement for 2-ampSO2CH3 (1), 2-ampSO2tmb (2),
Pt(2-ampSO2CH3)(Me2SO)Cl (3), and Pt(2-ampSO2tmb)(Me2SO)Cl (4)
1

2

3

4

Chemical formula

C7H10N2O2S⋅
HCl

C15H18N2O2S

C9H15ClN2O3PtS2 C17H23ClN2O3PtS2
⋅CH4O

Mr

222.69

290.37

493.89

630.08

Cell setting

Monoclinic

Monoclinic

Monoclinic

Monoclinic

space group

P21/c

P21/c

P21/c

P21/n

Temperature (K)

110

100

90

115

a(Å)

7.332 (2)

13.6863 (15)

14.7137 (17)

9.2130 (10)

b(Å)

14.067 (4)

11.5328 (12)

8.6927 (10)

21.591 (3)

c (Å)

9.474 (3)

18.838 (2)

10.5988 (15)

11.1716 (15)

β (°)

91.898 (11)

104.933 (4)

98.935 (7)

100.777 (7)

V (Å3)

976.6 (5)

2873.0 (5)

1339.2 (3)

2183.0 (5)

Z

4

8

4

4

Dx (Mg m–3)

1.515

1.343

2.450

1.917

µ (mm–1)

0.57

0.23

10.99

6.77

46928, 10432,
8039

30404, 5269,
4819

30100, 6696, 5494

0.028

0.025

0.021

0.033

30.5

32.6

33.7

30.8

R[F > 2s(F )],
wR(F2), S

0.036, 0.081,
1.06

0.043, 0.110,
1.02

0.026, 0.064, 1.09 0.058, 0.136, 1.24

No. of relections

2972
reflections

10432 reflections 5269 reflections

6696 reflections

No. of parameters

125

374

167

259

(Δ/σ)max

0.001

0.001

0.003

0.002

Δρmax, Δρmin (e Å–3) 0.42, –0.43

0.43, –0.45

1.58, –2.49

3.91, –3.93

Extinction
coefficient

0.0007 (2)

0.00150 (13)

No. of measured,
18808, 2972,
independent and
2403
observed reflections
Rint
θmax (°)
2

2
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Table D.2. Selected Bond and Atom Distances (Å) and Angles (deg) for Pt(2ampSO2CH3)(Me2SO)Cl (3) and Pt(2-ampSO2tmb)(Me2SO)Cl (4).
3

4

bond distances
Pt–N1

2.045 (3)

2.058 (7)

Pt–N2

2.029 (3)

2.039 (7)

bond angles
N1–Pt–N2

80.85 (11)

80.9 (3)

N1–Re–S

172.86 (8)

173.8 (2)

N1–Re–Cl

94.68 (8)

93.1 (2)

D.3 Pt(II) Complexes of Ethylenediamine- and Diethylenetriamine-Sulfonamide Ligands
D.3.1 Synthesis of Pt(tmbSO2-N,N-Me2dien)Cl (5).
A methanol solution (20 mL) of cis-Pt(Me2SO)2Cl2 (0.5 mmol, 211 mg) was treated with
tmbSO2-N,N-Me2dien (0.5 mmol, 156 mg) in the presence of triethylamine (500 µL). The
reaction mixture was allowed to stir at RT overnight. The yellow solid that precipitated was
collected, washed with diethyl ether and dried in vacuo; yield, 132 mg (48 %) Crystals obtained
from slow evaporation of the reaction filtrate were characterized by single-crystal X-ray
crystallography. 1H NMR (ppm) in DMSO-d6: 6.88 (s, 2H), 6.61 (b, NH), 3.03 (m, 4H, CH2),
2.84 (m, 4H, CH2), 2.81 (s, 3H, CH3), 2.73 (s, 3H, CH3), 2.73 (s, 6H, CH3), 2.19 (s, 3H, CH3).
D.3.2 Synthesis of Pt(tmbSO2-en)(Me2SO)Cl (6).
A methanol solution (20 mL) of cis-Pt(Me2SO)2Cl2 (0.25 mmol, 105 mg) was treated
with tmbSO2-en (0.25 mmol, 61 mg) in the presence of triethylamine (500 µL). The reaction
mixture was allowed to stir at RT overnight. The yellow solid that precipitated was collected,
washed with diethyl ether and dried in vacuo; yield, 57 mg (42 %). Crystals obtained upon
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addition of acetronitrile to the reaction filtrate were characterized by single-crystal X-ray
crystallography. 1H NMR (ppm) in DMSO-d6: 6.95 (s, 2H), 5.77 (s, 2H), 2.76 (b, 2H, CH2), 2.72
(s, 6H, CH3), 2.23 (s, 3H, CH3), 2.01 (b, 2H, CH2).
Table D.3. Crystal Data and Structural Refinement for Pt(tmbSO2-N,N-Me2dien)Cl (5) and
Pt(tmbSO2-en)(Me2SO)Cl (6)
5
6
Chemical formula

C15H26ClN3O2PtS

C13H23ClN2O3PtS2

Mr

542.99

549.99

Cell setting

Monoclinic

Monoclinic

space group

P21/c

P21/c

Temperature (K)

90

90

a (Å)

15.075 (3)

19.7581 (15)

b (Å)

13.191 (3)

7.5133 (5)

c (Å)

9.6030 (15)

11.8480 (10)

β (°)

105.167 (13)

91.003 (5)

V (Å3)

1843.1 (6)

1758.5 (2)

Z

4

4

Dx (Mg m–3)

1.957

2.077

μ (mm–1)

7.88

8.38

No. of measured,
independent and observed
reflections

26111, 6660, 4340

54939, 11293, 9138

Rint

0.057

0.025

θmax (°)

32.6

41.4

R[F2 > 2σ(F2)], wR(F2), S

0.044, 0.093, 1.03

0.030, 0.075, 1.06

No. of relections

6660 reflections

11293 reflections

No. of parameters

212

205

(Δ/σ)max

0.001

0.002

Δρmax, Δρmin (e Å–3)

4.01, –2.09

2.41, –3.00

Extinction coefficient

0.00053 (11)

0.00213 (13)
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Figure D.4. Perspective drawings of Pt(tmbSO2-N,N-Me2dien)Cl (5). Thermal ellipsoids are
drawn with 50% probability.

Figure D.5. Perspective drawings of Pt(tmbSO2-en)(Me2SO)Cl (6). Thermal ellipsoids are
drawn with 50% probability.
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